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Abstract 
Researchers have shown a relationship between mental health disorders and alcohol 
dependence. However, only 5-10% of individuals with substance use problems co-
occurring with mental health problems are correctly identified. The purpose of this 
research was to identify predictors  of relapse using three different instruments of varying 
complexity: the Patient Health Questionnaire-9 (PHQ-9), the Modified Mini Screen 
(MMS), and the Millon Clinical Multiaxial Inventory-III (MCMI-III). Researchers have 
found that using alcohol produces relief, similar to a pharmacological intervention, from 
troublesome mental health symptoms that individuals experience. Considering this 
association, the self-medication hypothesis was the conceptual lens used for the study as 
it provides a practical framework for analyzing the relationship between mental health 
disorders and relapse. At the request of this researcher, data were collected on 45 
individuals who were provided detoxification services at a public treatment facility in 
central Wisconsin. Regression analyses were conducted and identified a statistically 
significant, although weak, predictive relationship between relapse and the variable of 
depression as measured by the PHQ-9 (R = .311
a
, R
2
 = .097, p = .037), and depression as 
measured by the MCMI-III (R = .364
a
, R
2
 = .133, p = .014). The implications for positive 
social change from this study include the potential to increase the effectiveness and 
efficiency in identifying co-occurring mental health disorders among individuals who are 
treated for alcohol detoxification, enhancing the accuracy of referrals for aftercare, and 
reducing readmissions for detoxification amongst the individuals served.  
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Chapter 1: Introduction to the Study 
Introduction 
This exploratory study examines depression, anxiety, psychosis, and personality 
disorders, as identified by three different instruments: the Patient Questionnaire-9 (PHQ-
9), the Modified Mini Screen (MMS), and the Million Clinical Multiaxial Inventory-III 
(MCMI-III). These instruments were utilized to identify predictors of relapse in 
individuals who have been previously detoxified from alcohol. The criterion variable 
involved in this study was the number of days to relapse, within the first 90 days 
following initial detoxification, resulting in readmission for alcohol detoxification. 
An additional possible outcome of this research included the potential to improve 
identification of co-occurring mental health disorders in individuals presenting for 
alcohol detoxification. Other possible outcomes were implementation of standardized 
instrumentation to identify individual mental health disorders in detoxification settings, 
and increased emphasis on rehabilitation and recovery services following alcohol 
detoxification. The overall intent of this research was to improve the human and social 
conditions for people with co-occurring disorders. 
This chapter includes a summary of the literature, the research problem and 
questions, hypotheses tested, theoretical framework, basic definitions, assumptions, 
scope, limitations, and significance. Additionally, the nature of the study is summarized 
in this chapter. 
                                             Background                                                                                           
 Readmission rates are a commonly used, yet poorly-understood quality indicator 
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for alcohol detoxification services. When researchers focus on readmission rates rather 
than the interrelated co-occurrence of mental health disorders, they may support treating 
these conditions independently (McGovern, Xie, Segal, Siembab, & Drake, 2006). 
According to the Diagnostic and Statistical Manual, Fifth Edition (DSM-V), there 
is an association between mental health disorders and alcohol dependence, and symptoms 
of mental health disorders often present prior to the onset of alcohol abuse (American 
Psychiatric Association, 2013). Drake, O'Neal, and Wallach (2008) found that when 
mental health symptoms are not addressed, the likelihood of treatment dropout increases.  
Researchers have shown that patients who receive post discharge treatment have better 
outcomes in both abstinence from alcohol use and decreased readmission rates (Daley, 
Argerious, & McCarty, 1998).  
Green-Hennessy (2002) indicated the likelihood of receiving treatment increases 
with the presence and severity of mental health disorders. However, Harris and Edlund 
(2005) found that only 5-10% of individuals with mental health disorders co-occurring 
with alcohol use problems are correctly identified; therefore, they may not be referred to 
the appropriate treatment programs. Researchers have found that predicting relapse after 
alcohol detoxification is important to ensure that people are directed to the most 
appropriate aftercare services (Pedersen & Hesse, 2009). A valid and practical instrument 
for predicting risk for relapse does not exist; therefore, individuals may not be correctly 
targeted for aftercare services. If individuals are not provided with the appropriate 
aftercare services, the likelihood of relapse increases (Nakajima & al’Absi, 2012).                                                                                             
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The co-occurrence of alcohol use disorders with mental health disorders has been 
extensively documented, however literature examining mental health disorders as 
predictors of relapse in previously detoxified individuals is lacking. Multiple literature 
searches were conducted which yielded thousands of articles focused on the co-
occurrence of alcohol use disorders with mental health disorders. However; literature that 
specifically examines the impact of mental health disorders as a predictor of repeated 
admissions for detoxification from alcohol is minimal. In my dissertation I sought to 
address this gap in the literature by examining the interaction between mental health 
disorders with alcohol to predict relapse in detoxified patients.  
Problem Statement 
Alcohol abuse has multiple causes, with genetic, physiological, psychological, 
and social factors all playing a role (Drake et al., 2008). For some individuals, mental 
health disorders prompt excessive alcohol use. Some individuals use alcohol to cope with 
psychological problems. Co-occurring disorders are associated with an increased severity 
of alcohol dependence as compared with alcohol use disorders alone (Chakroun, Johnson, 
& Swendsen, 2010). Chávez, Dinsmore, and Hof (2010) indicated that being diagnosed 
with a personality disorder is a strong predictor of alcohol use disorders.                                                                                                                                                           
 Lagoni, Crawford, and Huss (2011) found that individuals with mental health 
disorders are significantly more likely to have alcohol use disorders as compared to the 
general population, are less likely to be successful in treatment, and are more likely to 
relapse following treatment. Identifying mental health disorders in individuals who 
present for alcohol detoxification, and subsequently referring these individuals to the 
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appropriate treatment services, provides the opportunity to address the source of the 
issue, thus enhancing the potential for recovery and reducing the risk of relapse (Bradizza 
et al., 2009). The identification of predictors of relapse in the population of people 
receiving alcohol detoxification services may be useful to ensure that individuals who 
have the highest need for aftercare services are identified, and to make the best use of the 
limited resources that are available (Pedersen & Hesse, 2009).  
Purpose of the Study 
This was a quantitative study and utilized a nonexperimental design to answer the 
research questions. The purpose of this study was to identify predictors of relapse in 
patients detoxified from alcohol. Predictor variables of this study included depression, 
anxiety, psychosis, and personality disorders as measured by three different instruments 
(PHQ-9, MMS, and MCMI-III). The criterion variable involved in this study was the 
number of days to relapse, within the first 90 days following initial detoxification, 
resulting in readmission for alcohol detoxification.  
Research Questions and Hypotheses 
The following research questions and hypotheses were developed to explore if the 
three selected instruments effectively measure variables, which in turn are potentially 
able to predict relapse in individuals who have been previously detoxified from alcohol.   
Three different instruments of varying complexity were selected for use in this study to 
solicit data targeted to answer the research questions.                                                      
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Research Question 1: Does depression, as measured by the Patient health 
Questionnaire-9 (PHQ-9), significantly predict relapse among individuals within 90 days 
following alcohol detoxification?  
Ho1: Depression does not significantly predict relapse in previously detoxified 
individuals. 
Ha1: Depression significantly predicts relapse in previously detoxified 
individuals. 
Research Question 2:  Does depression, as measured by the Modified Mini Screen 
(MMS), significantly predict relapse among individuals, within 90 days following alcohol 
detoxification?  
Ho2: Depression does not significantly predict relapse in previously detoxified 
individuals. 
Ha2: Depression significantly predicts relapse in previously detoxified 
individuals. 
Research Question 3: Does depression, as measured by the Millon Clinical 
Inventory-III (MCMI-III), significantly predict relapse among individuals, within 90 days 
following alcohol detoxification?  
Ho3: Depression does not significantly predict relapse in previously detoxified 
individuals. 
Ha3: Depression significantly predicts relapse in previously detoxified 
individuals. 
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Research Question 4:  Does anxiety, as measured by the MMS, significantly 
predict relapse among individuals, within 90 days following alcohol detoxification?  
Ho4: Anxiety does not significantly predict relapse in previously detoxified 
individuals. 
Ha4: Anxiety significantly predicts relapse in previously detoxified individuals. 
Research Question 5: Does anxiety, as measured by the MCMI-III, significantly 
predict relapse among individuals, within 90 days following alcohol detoxification? 
Ho5: Anxiety does not significantly predict relapse in previously detoxified 
individuals. 
Ha5: Anxiety significantly predicts relapse in previously detoxified individuals. 
Research Question 6:  Does psychosis, as measured by the MMS, significantly 
predict relapse among, individuals within 90 days following alcohol detoxification?  
 Ho6: Psychosis does not significantly predict relapse in previously detoxified 
individuals. 
 Ha6: Psychosis significantly predicts relapse in previously detoxified individuals. 
Research Question 7:  Does psychosis, as measured by the MCMI-III, 
significantly predict relapse among individuals, within 90 days following alcohol 
detoxification?  
 Ho7: Psychosis does not significantly predict relapse in previously detoxified 
individuals. 
 Ha7: Psychosis significantly predicts relapse in previously detoxified individuals. 
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Research Question 8: Do personality disorders, as measured by the MCMI-III, 
significantly predict relapse among individuals, within 90 days following alcohol 
detoxification?   
Ho8: Personality disorders do not significantly predict relapse in previously 
detoxified individuals. 
 Ha8: Personality disorders significantly predict relapse in previously detoxified 
individuals.                                                                                                                                
 An element of this study design was the use of multiple instruments that measure 
similar clinical issues. This information may be important for clinicians and program 
administrators to know to assist in facilitating the use of the most effective and efficient 
instrument in alcohol detoxification settings. 
  The facility the study was conducted in uses the PHQ-9 and MMS within their 
mental health and substance abuse outpatient clinics, therefore familiarity with these 
instruments existed. The use of the same instruments for this study occurred to align with 
current practice and anticipated future practice within the organization. However, the 
PHQ-9 is only designed to potentially identify one predictor variable, depression, and the 
MMS identifies only three potential predictor variables: depression, anxiety, and 
psychosis. The MCMI-III was selected for use as it has the capability to potentially 
identify all predictor variables included in the study: depression, anxiety, psychosis, and 
personality disorders.                                                                                                                               
 Data were collected by facility staff at my request to allow the study to be 
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conducted. Table 1 identifies each predictor variable, and the specific instrument or 
instruments used to identify these variables.   
Table 1 
Instrumentation Utilized to Identify Predictor Variables 
 
Predictor Variable PHQ-9 MMS MCMI-III 
Depression X X X 
Anxiety  X X 
Psychosis  X X 
Personality Disorders   X 
 
 Bivariate regression analyses were conducted to explore and examine the ability 
of each predictor variable as identified by each of the three instruments in predicting 
relapse in the study population. A more thorough explanation of the research methods 
and design are discussed in Chapter 3 of this dissertation. 
Theoretical Framework for the Study 
Self-Medication Hypothesis 
Building upon his earlier research, Khantzian (1985) explored the psychotropic 
effects of heroin and cocaine, and the interaction that occurs with mental health 
disturbances and unpleasant affective states. He noted that individuals addicted to heroin 
and cocaine often had histories of aggression and depression that long preceded their use 
of any illegal drugs. Additionally, Khantzian found that many individuals reported relief 
from depressive symptoms, anger, and rage when using these drugs, and subsequently 
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used them as medication to alleviate disturbing symptoms (Khantzian, 1985). Potvin, 
Stip, and Roy (2003) described the self-medication hypothesis similarly to Khantzian, 
indicating alcohol is used in place of a pharmacological intervention, to obtain relief from 
distressing mental health symptoms. Therefore, with relief of certain target symptoms, 
substance use and subsequent need for detoxification services may be less of a necessity 
(Potvin et al., 2008).   
Primary theoretical propositions of the self-medication hypothesis include: some 
individuals have an inability to tolerate strong negative affect; the inability to tolerate 
strong affect is a primary motivator for substance use in these individuals; and mental 
health conditions are the causal agent in substance use. Chakroun et al. (2010) provided 
support for these propositions by reporting certain individuals use substances in an 
attempt to self-medicate intolerable affective states. According to this hypothesis, an 
individual's use of alcohol or other substances is not accidental, but chosen for its ability 
to relieve distressing symptoms or feelings (McDonald & Meyer, 2011).  
The self-medication hypothesis has been identified as a potential explanation for 
co-occurring disorders; however according to Mueser, Drake, and Wallach (1998), a 
review of etiological theories finds little evidence for this hypothesis. According to Hall 
and Queener (2007), few theories exist explaining the origination of alcohol dependence, 
how this dependence is maintained, and how such self-destructive behavior can be 
preferred in spite of such significant negative consequences. While there are some 
contrary findings, much of the relevant research supports the self-medication hypothesis.  
The self-medication hypothesis has over 30 years of empirical research behind it and has 
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received recognition and acceptance in professional literature, which has resulted in the 
use of this theory for this study. A detailed review of the self-medication hypothesis 
occurs in Chapter 2 of this dissertation. 
This study examined if depression, anxiety, psychosis, and personality disorders, 
were able to significantly predict relapse following alcohol detoxification services.  
Research questions were designed to examine the predictive relationship between specific 
mental health disorders and relapse from alcohol detoxification services. 
Nature of the Study 
Rationale 
Pharmaceutical interventions have been proven helpful for individuals who are 
plagued with troubling symptoms of mental illness (Witkiewitz, 2011). However, if such 
interventions are not available, individuals may choose to use alcohol or another 
substance to manage distressful symptoms. Castaneda, Galanter, and Franco (1989) 
presented three factors necessary for substance use to be considered self-medication; the 
presence of a mental health disorder that typically responds to treatment with medication, 
the absence of such medication, and the self-administration of a chemical that is a 
substitution for medication. Considering the concept of self-medication, a primary 
question related to readmissions for alcohol detoxification in this population arises; are 
mental health disorders a predictor of relapse in detoxified patients? 
A quantitative approach was chosen for this study as it provided an opportunity to 
utilize data collected by the facility staff, as requested by this researcher, to explore 
whether or not the selected predictor variables can each adequately predict relapse, the 
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criterion variable. Predictor variables including depression, anxiety, psychosis, and 
personality disorders, were collected and measured using validated instruments, which 
included the MMS, the MCMI-III, and the PHQ-9. The criterion variable, number of days 
to relapse, within the first 90 days following initial detoxification, resulting in 
readmission for alcohol detoxification, was collected by monitoring the daily census of 
the detoxification units and identifying admissions. The daily census was monitored 90 
days post discharge from detoxification services for each subject to obtain actual number 
of days to relapse. Data collected was analyzed using the statistical procedure of 
bivariate, simple linear regression.   
Key Study Variables                                                                                                          
 As indicated earlier, the predictor variables included depression as measured by 
the PHQ-9, depression as measured by the MMS, depression as measured by the MCMI-
III, anxiety as measured by the MMS, anxiety as measured by the MCMI-III, psychosis 
as measured by the MMS, psychosis as measured by the MCMI-III and personality 
disorders as measured by the MCMI-III. The criterion variable was number of days to 
relapse, within the first 90 days following initial detoxification, resulting in readmission 
for alcohol detoxification.   
Definition of Key Terms.  Key terms used throughout the current research study 
are defined below:                                                                                                     
Aftercare: stage of treatment that follows current services after the patient no longer 
requires such intensity. Such services are designed to support and sustain the process of 
recovery (Wisconsin Administrative Code, 2011).  
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Ambulatory detoxification: medically monitored detoxification services that are 
delivered on an outpatient basis (Wisconsin Administrative Code, 2011). 
Co-occurring disorders is defined as the presence of one or more mental health 
disorders in addition to an alcohol use disorder (Jahng et al., 2011). 
Detoxification is defined as the resolution of alcohol intoxication (Wisconsin 
Administrative Code, 2011). 
Psychotropic drug is defined as a prescription drug that is used to treat or manage  
 
a mental health symptom or challenging behavior (Wisconsin Administrative Code,  
 
2014). 
 
Relapse is defined as number of days from discharge to readmission for 
detoxification services (Witkiewitz, 2011). 
Wisconsin Uniform Placement Criteria (WI-UPC) is defined as a placement 
 
instrument that generates a placement recommendation as to an appropriate level of care  
 
at which a patient should receive services (Wisconsin Administrative Code, 2011).  
 
Assumptions 
Given that the screening tools used to identify mental health disorders in the 
target population rely on the self-report of participants, it was assumed that participants 
would answer honestly. Additionally, it was assumed that the diagnoses selected as 
predictor variables in the study had the potential to predict relapse.  
Scope and Delimitations 
Focusing on mental health disorders in the population of people who present for 
detoxification from alcohol was selected as the specific focus of this study. Providing 
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detoxification services in isolation of addressing such disorders may be treating the 
symptom without addressing the cause. This may result in the recurrence of symptoms 
(Regier et al., 1990). Predicting relapse after detoxification from alcohol may be useful in 
targeting patients for aftercare services to make the best use of limited resources (Chavez, 
Dinsmore, & Hof, 2010).   
The facility the study occurred in has two detoxification programs. One is located 
within the psychiatric hospital and the other is an ambulatory detoxification program. All 
patients admitted to alcohol detoxification services, throughout the state of Wisconsin, 
are required to meet criteria based on a state approved placement instrument. The state of 
Wisconsin has approved the use of two placement instruments; the Wisconsin Uniform 
Placement Criteria (WI-UPC) and the American Society of Addiction Medicine 
placement criteria (ASAM). The facility the study occurred in, utilizes the WI-UPC. The 
use of this instrument provides assurance that patients are placed into the appropriate 
level of care to meet their presenting care needs (Wisconsin Administrative Code, 2011).  
The readmission rates identified above represent only the hospital based program.  
Effective January 1, 2014, data collection for the measurement of readmission rates in the 
ambulatory detoxification program was initiated. It was anticipated that the overall 
readmission rates for the combined detoxification programs may increase due to the 
inclusion of the ambulatory detoxification program. This study used a convenience 
sample; therefore the results are only generalizable to populations that share similar 
demographics. 
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Limitations 
Limitations of this study included the use of a small convenience sample and 
reliance on self-report. Using a convenience sample limits the generalizability of the 
results, therefore this needs to be considered if applying or considering results in other 
settings.    
Significance 
Understanding predictors of relapse requiring admission for alcohol detoxification 
services is important for improving the treatment and prevention of mental health and 
alcohol use problems. Timely identification and treatment of mental health disorders may 
be a key in the recovery of individuals with co-occurring disorders (Lagoni et al., 2011).   
If the standardized screening instruments used in this study are able to effectively identify 
co-occurring mental health disorders in the study population, the use of such instruments 
may be a practice to consider implementing in detoxification settings.   
Placing an emphasis on the importance of rehabilitation and recovery services 
following detoxification and implementing strategies to engage this population into such 
aftercare services has the potential to improve the quality of life for individuals with 
alcohol dependence. Additionally, to make the best use of limited resources, it is 
important to identify individuals who demonstrate a need for aftercare services and focus 
on getting these individuals into services following detoxification. The intent of this 
research was to improve the human and social conditions for people with co-occurring 
disorders. 
15 
  
   
 
    Summary                                                                                                                          
 This study aimed to identify predictors of relapse in patients detoxified from 
alcohol at a public treatment facility, located in central Wisconsin. Predictor variables 
selected for use in this study included depression, anxiety, psychosis, and personality 
disorders as measured by three different instruments (PHQ-9, MMS, and MCMI-III). The 
PHQ-9 was used to identify depression; the MMS was used to identify depression, 
anxiety, and psychosis; and the MCMI-III was used to identify depression, anxiety, 
psychosis, and personality disorders.  
The criterion variable involved in this study was number of days to relapse, within 
the first 90 days following initial detoxification, resulting in readmission for alcohol 
detoxification. If identified properly, individuals with mental health disorders can be 
referred for aftercare to address their mental health needs, which may improve their 
potential for a successful recovery from alcohol abuse, and potentially decrease future 
need for repeated detoxification services. 
The literature review that follows in Chapter 2 integrates research that addresses 
the relationship between alcohol use and mental health disorders, as well as the impact of 
the co-occurrence of these issues.   
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Chapter 2: Literature Review 
Introduction 
Individuals with mental health disorders are significantly more likely to have 
alcohol use disorders as compared to the general population, are less likely to be 
successful in treatment, and are more likely to relapse following treatment (Lagoni et al., 
2011). Identifying mental health disorders in individuals who present for alcohol 
detoxification, and subsequently referring these individuals to the appropriate treatment 
services, provides the opportunity to address the source of the issue, thus enhancing the 
potential for recovery and reduce the risk of relapse (Bradizza et al., 2009).   
The purpose of this study was to explore and evaluate the potential impact of 
mental health disorders as possible predictors of relapse in patients detoxified from 
alcohol. The ability to predict relapse after treatment for detoxification from alcohol may 
be useful to ensure that individuals who have the highest need for aftercare services are 
identified and to make the best use of the limited resources that are available (Pedersen & 
Hesse, 2009).  
The co-occurrence of alcohol use disorders with mental health disorders has been 
extensively documented, however literature examining mental health disorders as 
predictors of relapse in previously detoxified individuals is lacking. Multiple literature 
searches were conducted which yielded thousands of articles focused on the co-
occurrence of alcohol use disorders with mental health disorders. However, literature that 
specifically examines the impact of mental health disorders as a predictor of repeated 
admissions for detoxification from alcohol is minimal. In my dissertation I sought to 
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address this gap in the literature by examining the interaction between mental health 
disorders with alcohol to predict relapse in detoxified patients. 
The literature review presented in this chapter is divided into six sections. The 
first section provides an overview of the literature search. The second section presents a 
rationale for the present study, which includes two components: exploring the 
relationship between mental health disorders and relapse to alcohol use after 
detoxification has occurred, and examining mental health disorders as valid predictors of 
relapse. 
The concept of co-occurring disorders is addressed in the third section, which is 
followed by a review of three different frameworks that have been used to examine self-
medication in the fourth section. The final section entails a detailed review of the self-
medication hypothesis, which is the hypothesis of primary interest for this research.   
Rationale 
Several researchers including Heinz et al. (1999), Franken and Hendriks (1999), 
Driessen et al. (2001), Strowing (2000), Chakroun et al. (2010), Littlefield and Sher 
(2010), and Dick et al. (2010) have reported findings indicating  the presence of 
depression increases the risk of relapse in individuals who have stopped using alcohol.  
However, Greenfield et al. (1998) and Grant et al. (2004) indicated that depressive 
symptoms are not valid predictors of relapse. In general, findings from research 
conducted on the effects of mental health disorders on relapse are contradictory at best. 
This purpose of this study was to evaluate the impact of mental health disorders 
including depression, anxiety, psychosis, and personality disorders, on predicting relapse 
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in previously detoxified patients. Witkiewitz and Villarroel (2009) defined relapse as a 
return to alcohol use after a period of abstinence. Addtionally, Witkiewitz and Villarroel 
found that a negative affect is linked to reinitiation of alcohol use after sustaining a 
period of time without such use. Later work conducted by Witkiewitz (2011) suggested 
that a 90 day period of time, is an effective measure of relapse. 
Literature Search 
The databases used in the literature search included EBSCO, MEDLINE with Full 
Text, PsycARTICLES, Psych BOOKS, PsycEXTRA, PsycINFO, and SocINDEX with 
Full Text. Additionally, the following web sites were searched for pertinent literature: (a) 
National Institute on Alcohol Abuse and Alcoholism, (b) Firstgov.gov, (c) The Substance 
Abuse and Mental Health Services Administration, and (d) Science.gov. An open year 
search, limited to peer reviewed sources, was conducted. The following terms were used 
to search each database individually and in combination with each other: alcohol, alcohol 
abuse, alcohol use disorder, AOD, AODA, detoxification, predictors, relapse, mental 
illness, mental health, mental health disorders, co-occurring, comorbidity, self-
medication, self-medication hypothesis, depression, mood disorders, anxiety disorders, 
psychotic disorders, personality disorders, remission, treatment, literature review, and 
meta-analysis.   
Articles were selected for inclusion into the current research if they specifically 
addressed a relationship between mental health disorders and alcohol use which results in 
admission for detoxification services. The use of prescribed drugs to address symptoms 
of mental health disorders was not explored in this literature search. The majority of the 
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articles reviewed did not address the connection between mental health disorders and the 
use of alcohol resulting in detoxification services. Research obtained was used to explore 
this connection and confirm or negate whether or not this connection shows relevancy 
regarding relapse after detoxification has occurred. 
Current scientific literature focused on the connection between mental health 
disorders and alcohol is abundant; however, there is a lack of information focused on the 
potential of a connection between the use of alcohol detoxification services and presence 
of a mental health disorder. Additionally, the majority of study designs relied on the long 
term recall of selected samples of patients with advanced alcohol use disorders. 
Individuals may not accurately recall the sequence of the onset of mental health 
symptoms and alcohol use.  
Much of the research that is relevant to the proposed study is older than five 
years. The current research will bridge this gap by relating new findings to previous 
findings, with the intended goal of determining if there is evidence that suggests having a 
mental health disorder increases the likelihood of repeated admissions for alcohol 
detoxification services, and if specific mental health disorders can predict the likelihood 
of such repeated admissions. 
Co-Occurring Disorders 
Definition and Prevalence 
 Co-occurring disorders, also known as comorbidity, can be defined as the 
expression of two or more disorders or conditions that coexist, however each can also 
stand independently (McGovern, Wrisley, & Drake, 2005). While two or more disorders 
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may occur at the same time in an individual, the prevalence of some combinations are 
much higher than others. 
 Deykin, Levy, and Wells (1987) conducted research that utilized the Diagnostic 
Interview Schedule (DIS), on 424 college-age students, aged 16 to 19 years old. Male and 
female students who met criteria for alcohol abuse or dependence were more likely to be 
diagnosed with a major depressive disorder than those who did not meet criteria. Males 
were approximately four times more likely and females six times.     
 Regier et al. (1990) published a widely-known study addressing the issue of co-
occurring disorders. Data for this research were obtained from the Epidemiological 
Catchment Area (ECA) study of the National Institute of Mental Health (NIMH), which 
utilized the DIS and included 20,291 adults, aged 18 years and older. Of those with 
alcohol use disorders, 36% had a mental health disorder. Over half (53.1%) of those with 
a drug use disorder had a psychiatric disorder. The odds of having a mental health 
disorder if the person had an alcohol or drug use disorder doubled and quadrupled, 
respectively (Regier et al., 1990).  
 These investigators also examined the rates of alcohol use disorders among those 
with specific mental health disorders and found that 25% to 33% also had a substance use 
disorder (Regier et al., 1990). Regier et al. (1990) identified the highest lifetime 
prevalence of alcohol use disorders in the population of people with bipolar disorder, 
56.1%, followed by those with schizophrenia at 47%.    
 Chávez, Dinsmore, and Hof (2010) examined the correlation between antisocial 
and borderline personality disorders and alcohol use disorders. They found that both 
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personality disorders are associated with high rates of alcohol abuse. Eighty-five percent 
of those with antisocial personality disorder were diagnosed with alcohol abuse, whereas 
47% of those with borderline personality disorder were diagnosed with alcohol abuse.  
Kimonis, Tatar, and Cauffman (2012) conducted similar research on juvenile offenders 
and reported results consistent with research conducted on adults. They found that 
juveniles with secondary variants of mental health disorders are at increased risk for 
alcohol use disorders.  
 The National Comorbidity Studies (NCS), conducted by Kessler, which were 
published in 1994 and 1997, are foundational studies in the area of co-occurring 
disorders. The NCS utilized a national study approach and utilized a fully structured 
interview, entitled the NCS Interview Schedule, and subsequently the NCS-Replication 
(NCS-R) Interview Schedule, that was administered face-to-face by trained lay 
interviewers. This scope of this study (N = 8,098) was large and included the general 
population to identify the proportion of the population that disorders occur in. Using a 
national study approach avoids selection biases and results in statistics that are 
generalizable for the population as a whole. 
 Kessler et al. (1994) found at least one mental health disorder in almost half of the 
population. Approximately 60% of the population identified with a mental health disorder 
had a co-occurring substance abuse disorder. Even higher rates of co-occurrence were 
found in study participants with schizophrenia and bipolar disorder; however, the 
incidence of depression is higher in the general public, which results in more people with 
concurrent substance use and depression.      
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   Other examples of using a national study approach are the Epidemiologic 
Catchment Area Study (Robins & Regier, 1991) and the National Longitudinal Alcohol 
Epidemiologic Survey (Grant, 1995). Like the NCS, the Epidemiologic Catchment Area 
Study sampled the general population and used the DIS to identify mental health 
disorders. Whereas the 42,862 participant National Longitudinal Alcohol Epidemiologic 
Survey conducted by Grant (1995) focused specifically on depression and the co-
occurrence of alcohol use in the civilian, noninstitutionalized, U.S. adult population. The 
Alcohol Use Disorder and Associated Disabilities Interview Schedule – DMS IV Version 
(AUDADIS-IV), which is a structured diagnostic interview designed for use by lay 
interviewers, was utilized to gather data from participants. 
 Kessler, Chiu, Demler, and Walters (2005) conducted a replication of the National 
Comorbidity Survey (NCS-R) that included 9,282 adults from across the United States.  
This replication survey found that although mental health disorders are widespread, 
serious cases are concentrated amongst a relatively small portion of cases with high co-
occurrence, which concurred with results from the original research. Results from the 
NCS-R identified the same three most prevalent disorders as the NCS, which include 
specific phobia, social phobia, and major depressive disorder. This research also found 
the prevalence of anxiety disorders was higher than mood disorders, and that mood 
disorders are more prevalent than alcohol use disorders. The implications of these 
findings suggest it is more likely to have alcohol use disorders co-occur with another 
mental disorder than to have an alcohol use disorder alone.  
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 Cacciola, Alterman, Rutherford, McKay, and Mulvaney (2001) conducted an 
extensive literature review examining prevalence rates of mental health disorders in 
addiction treatment settings. These authors reported a wide variability in prevalence rates 
across a number of studies; however this variability is noted to be the result of different 
measures, methods, settings, populations, and diagnostic criteria utilized to obtain results.  
In spite of the variability, a consistent pattern did emerge, indicating that people with 
alcohol use disorders are likely to suffer from mood and anxiety disorders. Cacciola et al. 
went on to conduct a study that included 310 lower socio-economic, opiate dependent 
patients who were in their first 3-6 weeks of treatment.   
 The Structured Clinical Interview for DSM-III-R (SCID) was used to determine 
eligibility for the study. Individuals with dementia, mental retardation, schizophrenia, and 
active psychosis were excluded due to the extensive assessment process. The SCID for 
DMS-III Personality (SCIDP-R), Addiction Severity Index (ASI), and SCID were 
utilized to obtain research data. Cacciola et al. (2001) observed that a majority (75.2%) of 
participants had a co-occurring mental health disorder. Additionally, these authors found 
that 78% of the participants had personality disorders, which suggests such disorders tend 
to co-occur in the substance abuse population. 
 Drake, Mueser, and Brunette (2007) conducted a review of literature to examine 
the relationship between severe mental health disorders and substance use disorders.  
These researchers reported that 50% or more of adults with severe mental health 
disorders had a co-occurring substance use disorder. Drake et al. recommended that all 
programs designed for people with severe mental health disorders should embrace the 
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fact, that having both a mental health disorder,  along with a substance use disorder is the 
norm, rather than the exception, and should consider and prepare their programs to be 
geared toward co-occurring disorders. 
 Bradizza et al. (2009) researched a population of 278 individuals who were 
diagnosed with severe mental health disorders including schizophrenia-spectrum or 
bipolar disorder and a co-occurring alcohol use disorder. Participants were assessed prior 
to beginning treatment and six months later using the Brief Symptom Inventory, the 
Structured Clinical Interview for the Positive and Negative Syndrome Scale (SCI-
PANSS), and the DIS-IV.   
 Treatment consisted of group and individual sessions. Group sessions covered 
topics such as education regarding co-occurring disorders, changing negative thinking, 
overcoming denial, coping with negative emotions, relapse prevention, coping with 
craving, and an introduction to 12-step groups. Individual sessions focused on coping 
with relapse, education regarding substance abuse, social services, housing, and dealing 
with social stressors. Psychiatric services, including psychopharmacology were also 
included in this program. Results of this study demonstrate a favorable prognosis for 
alcohol outcomes when treating the mental health disorder and alcohol use disorder 
together and incorporating psychosocial intervention as part of the treatment (Bradizza et 
al., 2009). 
 Grant et al. (2004) published the results of their study entitled the “National 
Epidemiologic Survey on Alcohol and Related Conditions” (NESARC), which focused 
on the most common disorders in the general population: mood, substance use, and 
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anxiety disorders. Combined, these disorders affect as many as 60 million people in the 
United States alone. The purpose of this research was to examine the prevalence and 
associations of substance use disorders and independent mood and anxiety disorders.  
The target population included civilian, non-institutionalized, adults who reside in the 
United States, including Alaska and Hawaii, and included 43,093 respondents. The 
AUDADIS-IV was utilized to gather data from participants. Findings from this study 
were consistent with Regier and colleagues and suggest about one in five persons with a 
substance use disorder had either a mood or anxiety disorder. Individuals with drug use 
disorders were more likely than those with alcohol use disorders to have a mental health 
disorder.   
 There is likely a difference between people who have a problem and do not seek 
treatment and those who do seek treatment, and it could be assumed that those who seek 
treatment are suffering greater degrees of severity or impairment. However, when 
examining the rates of co-occurring disorders among those seeking treatment, the Grant 
et al. study found the degree of overlap to dramatically increase, particularly among those 
with substance use disorders. Mood disorders were identified in 40.69 % of those with an 
alcohol use disorder and anxiety disorders were identified in 33.98% of this population.  
Like Regier et al. (1990), Grant et al. (2004) demonstrated rates that increased 
significantly when considering drug use, with 60.31% of people being identified with a 
co-occurring mood disorder and 42.63% with a co-occurring anxiety disorder.  
 Another avenue to examine co-occurring disorders is by using clinical 
investigation. Clinical investigation occurs within programs that are targeted for 
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individuals with specific disorders. Researchers identify two specific disorders they 
intend to investigate and then select samples with one of the two. Measuring the 
incidence of the second disorder then identifies co-occurrence.   
 Two different approaches are possible when using a clinical investigation to 
examine co-occurrence. One approach is to select for the mental health disorder first.  
Bibb and Chambless (1986) conducted research utilizing a clinical investigation and the 
mental health disorder first approach. Two hundred fifty four individuals receiving 
treatment for agoraphobia were involved in the study. Using the Michigan Alcohol 
Screening Test (MAST), these investigators found that 21% of the study population had 
co-occurring alcohol abuse.   
 Thyer et al. (1985) also studied a population of 156 individuals in treatment for 
agoraphobia, utilizing the mental health disorder first approach and found, using the 
MAST, that 17.3% had co-occurring alcohol abuse. Additionally, Thyer et al. reported 
that agoraphobic patients with a co-occurring affective disorder were especially prone to 
abuse alcohol.   
 Breslau, Andreski, and Kilbey (1991) utilized the mental health disorder first 
approach when conducting research on individuals who had a history of major depression 
and then looked for nicotine dependence within the study population. This study included 
1,007 young adults and found, using the Fagerström Tolerance Questionnaire (FTQ), 
which measures physiological dependence, individuals who have major depression are 
more likely to have co-occurring nicotine dependence.  
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 The other approach is to examine co-occurrence is by selecting for the substance 
use disorder first. The literature base utilizing this approach is much more robust, 
potentially due to the overtness of substance use disorders and the vast number of 
individuals who seek treatment for such issues. Many researchers have used this 
approach in studies including Woody, O’Brien, and Rickels (1975), Keeler, Taylor, and 
Miller (1979), Martin (1980), Rounsaville, Weissman, and Crits-Cristoph (1982), 
Rounsaville, Weissman, Kleber, and Wilber (1982), Schuckit (1985), Khantzian (1985), 
Rounsaville, Dolinsky, Babor, and Meyer (1987), Brown and Schuckit (1988), Castaneda 
et al. (1989), Rounsaville et al. (1991), Hughs (1993), Pomerleau, Collins, Shiffman, and 
Pomerleau (1993), Brown et al. (1995), Kinnunen, Doherty, Militello, and Garvey 
(1996), Lerman, Caporaso, Main, Audrain, and Boyd (1998), Cacciola et al. (2001), 
Willinger et al. (2002), and Suh et al. (2008). These researchers all select the substance 
use disorder first and look for mental health disorders within this population.   
 Studies that are particularly relevant to the current research include those 
conducted by Keeler et al. (1979), Schuckit (1985), Rounsaville, Dolinsky, Babor, and 
Meyer (1987), Brown et al. (1995), Willinger et al. (2002), and Suh et al. (2008) as they 
utilize the substance use disorder first approach, with the substance of investigation being 
alcohol. Additionally, Khantzian’s seminal research, “The Self-Medication Hypothesis of 
Addictive Disorders: Focus on Heroin and Cocaine Dependence,” conducted in 1985 is 
of significant interest as it has provided the foundation for future research using the self-
medication hypothesis of addiction and utilized the substance use disorder first approach.  
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Theoretical Foundation 
 Two major theoretical frameworks, namely; the hypothesis of comorbidity and 
the self-medication hypothesis have been used to explain the relationship between mental 
health disorders and alcohol use. The self-medication hypothesis has been selected for 
use in the proposed research; however both hypotheses are thoroughly reviewed in the 
following sections of this chapter. 
Hypothesis of Comorbidity 
 A large literature base exists supporting a relationship between mental health 
disorders and alcohol use, however what is less clear is the processes in which this 
relationship occurs (Swendsen & Merikangas, 2000). Considering the abundant base of 
literature on this relationship and the void of research related to the processes of the 
relationship, an examination of why this relation exists is in order.   
 Looking at the association between anxiety disorders and alcohol use, Kushner, 
Abrams, and Borchardt (2000) reviewed laboratory studies that examined the interaction 
between anxiety symptoms and alcohol use, clinical studies that looked at the effect of 
one co-occurring disorder upon the course of the other, family studies examining mental 
health disorders in the families of probands with at least one co-occurring disorder, and 
prospective studies examining the longitudinal relationship of co-occurring disorders.  
After synthesizing the research, these authors report that findings converge on the 
conclusion that both anxiety disorders and alcohol use disorders can initiate the other, 
especially in cases of alcohol dependence verse alcohol abuse alone. Further, evidence 
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from clinical studies suggests that anxiety disorders can contribute to ongoing alcohol 
abuse and dependence (Kushner et al., 2000).   
 Finally, Kushner et al. (2000) posited that short-term anxiety reduction from 
alcohol use, in concert with longer-term anxiety induction from chronic drinking and 
withdrawal, can initiate a vicious circular pathway of increasing anxiety symptoms and 
alcohol use that results in co-occurrence. 
 A primary challenge that exists when evaluating the relation between alcohol use 
and mental health disorders is the fact that depression is a frequent side effect of 
withdrawal from alcohol (Curran, Flynn, Kirchner, & Booth, 2000). Therefore, certainty 
that depression observed during the withdrawal period is the result of removing the 
alcohol is questionable. 
 In an attempt to explain co-occurring disorders, Merikangas (1990) identified two 
tracks into which the phenomena of co-occurrence can be classified: causal explanations, 
and those of shared etiology. Four hypotheses have stemmed from the two tracks, each 
having a strong following from experts in the field of comorbidity. Hypotheses include 
shared-etiology, causal, artifactual, and self-medication. 
 Shared etiology hypothesis. According to Hasin and Grant (2002) fundamental 
genetic and environmental factors are shared resulting in the co-existence of mental 
health disorders and substance abuse. Researchers such as Cadoret et al. (1996) and 
Maier and Merikangas (1996) have proposed this hypothesis as an explanation to co-
occurring disorders, however have also suggested this hypothesis has often been 
inconclusive and has received mixed support. 
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 Causal hypothesis. The Causal Hypothesis suggests that mental health disorders, 
primarily depression, are often found co-occurring with substance abuse, especially 
alcohol abuse, because abusing alcohol causes depression either directly or indirectly 
(Hasin & Grant, 2002).   
 Abraham and Fava (1999) postulated the direction of the relationship between 
depression and substance abuse depends on the substance used. Strong support for this 
hypothesis was found by these researchers in a study that included 385 patients, with 
major depressive disorder, and were evaluated for co-occurring drug dependence using 
the SCID. Results indicate that alcohol dependence following the onset of first life 
depression was more likely to occur in the population of study participants who used 
alcohol than those who used other substances.   
 Artifactual hypothesis. The premise of this hypothesis is that depression and 
depressive symptoms are often misdiagnosed and symptoms of substance use disorders 
mimic those of depressive disorders resulting in artificially high co-occurrence rates. In 
an attempt to determine if alcohol dependence and depression were associated, after 
ruling out the effects of acute intoxication and withdrawal, Hasin and Grant (2002) 
conducted a study that included 6,050 former drinkers who did not use drugs or smoke in 
the previous year. Hasin and Grant used the AUDADIS and found that an association was 
present, which contradicts the artifactual hypothesis and suggested that individuals who 
are in recovery from alcohol use should be provided treatment for depression as their 
symptoms are likely not related to withdrawal. 
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 The final explanation regarding the co-occurrence of mental health and substance 
use disorders is the self-medication hypothesis.  This hypothesis will be delved into in 
significant detail and is the psychological theory the current study is based on. 
Self-Medication Hypothesis 
 Background. The self-medication hypothesis is the most widely accepted 
psychological theory of addiction and has over 30 years of research supporting it. Early 
explanations of substance dependence focused on issues such as euphoria-seeking, self-
destruction, and peer pressure as a basis for the initiation of substance abuse and 
subsequent dependence. However, concurrently, psychoanalysts began to consider a 
different paradigm that included the potential of an association between substance abuse 
and mental health disorders (Khantzian, 1985).  
 In 1977, in research conducted by Edward Khantzian, focused on heroin and 
cocaine addiction, one of the first Self-Medication Hypotheses was developed 
(Khantzian, 1985). Khantzian explored the psychotropic effects of these drugs and how 
they interact with mental health disturbances and unpleasant affective states. This study 
found that unpleasant mental health states were relieved by use of these drugs and these 
drugs became irresistible to susceptible individuals (1985).  
 Prior to Khantzian, Conger (1951) proposed the tension-reduction hypothesis as a 
model for alcohol consumption. The model assumes that alcohol can reduce tension and 
people seek alcohol to avoid or reduce unpleasant stress (Young, Oei, & Knight, 1990).  
The theoretical framework of Conger’s tension-reduction hypothesis and Khantzian’s 
first version of the Self-Medication Hypothesis bear little difference (Lewis &Vogeltanz-
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Holm, 2002). Khantzian and Conger’s theories are similar in that both view substance use 
as a reactive behavior, a response to specific presenting situations. Khantzian 
conceptualized these situations as “painful affect,” and suggests the presence of these 
factors increase the susceptibility of alcohol abuse (Khantzian, 1985). On the other hand, 
Conger’s theory considers alcohol abuse as a relief response to alleviate the unpleasant 
feelings that go along with tension (Conger, 1951).  
The concept of coping comes into play when examining the impact of engaging in 
a behavior while in a negative affective state. Maisto, Carey, and Bradizza (1999) utilize 
social learning theory to explain the high prevalence of alcohol use in the college student 
population. This theory suggests that alcohol consumption is a method of coping utilized 
by college students to deal with daily demands. Drinking to cope is unquestionably 
synonymous with self-medication (Milkman & Frosch, 1973).  
Milkman and Frosch (1973) conducted a study focused on coping, and in 
particular, the relationship between psychological defense mechanisms and substance 
abuse. These researchers found a connection between the specific drug chosen and an 
individual’s compensatory defense needs. Study participants who selected heroin as their 
drug of choice reported doing so to provide relief of withdrawal and isolation, and those 
who selected amphetamines were typically seeking to increase their sense of self-worth 
and self-confidence. Milkman and Frosch considered these patients as being unable to 
improve self-worth and self-confidence without the assistance of these drugs due to their 
underlying mental health disorders.   
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Strahan, Panayiotou, Clements, and Scott (2011) explained why people with 
anxiety often present with alcohol problems. The self-medication hypothesis was 
examined to assess the relationship between social anxiety and alcohol use. The primary 
finding of the study was the identification of a significant relationship between social 
anxiety and alcohol use in the male individuals. Women did not show a significant 
relationship between social anxiety and alcohol use, which suggests that gender, may be 
an important moderator. 
The psychodynamic view of self-medication implies that substances are used to 
compensate for deficient ego function, whereas the substance used provides a buffer to 
reality for the individual (Koob, 2006). While this does not fully address the conscious 
behaviors of those that abuse substances, it does help to explain aspects of the 
dysfunctional and non-purposeful cycle of self-medication that seem to be contradictory.  
In summary, self-medication hypotheses conceptualize substance abuse as a response to 
alleviate a negative state. Self-medication assumes that individuals who have a mental 
health condition, typically depression or anxiety, might use substances in an effort to free 
themselves, even if only temporarily, from mental anguish. Self-medication could also be 
seen as using substances to achieve outcomes that could potentially be more effectively 
gained through prescribed medication (McKim, 2003). 
Theory-Grounded Conceptualizations of the Self-Medication Hypothesis 
Cognitive-intentional.  Looking at self-medicating behavior as a cognitive and 
intentional choice is one way to conceptualize substance use. This view suggests that 
individuals are contemplating their actions, and specifically choose to use a specific 
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substance to achieve a specific anticipated result. The choice is purposeful with the goal 
of reducing a negative state, most likely emotional distress. Self-medication has been 
suggested as an explanation in the causation of substance abuse by researchers (Henwood 
& Padgett, 2007; Khantzian, 1985; Martin, 1980; Schaub, Fanghaenel, & Stohler, 2008; 
Suh et al., 2008 Simon, 1981; & McDonald & Meyer, 2011). Supporters of the cognitive-
intentional model claim that substance use is directly related to the pharmacological 
effects of the drug. So, as a replacement for a medication that is prescribed for the 
individual, instead they seek out alternatives that mimic the actual intended effects of 
prescription medication. A concern regarding this hypothesis is that it is largely based on 
data derived from the self-report of substance users (Weiss, Griffin, & Mirin, 1992).   
In an early study using the self-medication as a hypothesis, Weiss et al. (1992) 
examined a group of 494 hospitalized drug abusers and focused on the self-medication of 
depression. These researchers used a “substance-first,” approach in the selection of study 
participants. Depression was selected as the disorder of focus due to the high frequency 
of depressive symptoms in individuals who abuse substances, and the proven 
effectiveness of pharmacological intervention to treat depression (Keeler et al., 1979; 
Weissman, 1979; Rounsaville, Wiessman, & Crits-Cristoph, 1982). Psychiatrists, using 
the Diagnostic and Statistical Manual of Mental Disorders, as a diagnostic guide, 
conducted repeated clinical interviews. Researchers compared reported frequency and 
effectiveness of substance use on depressive symptoms and found support for the self-
medication hypothesis and the cognitive-intentional component. Sixty-three percent of 
patients reported using substances to reduce depressive symptoms they were experiencing 
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(Weiss et al., 1992). Participants experiencing major depression demonstrated even 
higher rates, with 89% reporting the use of substances specifically for the purpose of 
reducing their symptoms. 
Another finding of interest was that 100% of men who were diagnosed with 
depression reported abusing substances for self-medicative purposes; whereas 81% of 
depressed women reported abusing substances for this purpose. In contrast, 55% of men 
who were not diagnosed with depression reported using substances for self-medicative 
purposes and 75% of non-depressed women reported using substances as self-medication 
(Weiss, et al., 1992). These results suggest that a primary component of the self-
medication hypothesis, the desire to reduce depressive symptoms, is acknowledged in the 
majority of those who abuse substances. This research suggests that self-medication in 
men increases along with symptom severity. However, self-medication in women does 
not appear to be impacted by symptom (Weiss et al., 1992).  
The Weiss study does present some limitations, including the reliance on self-
report and as the homogeneity of the study population, which makes generalizability of 
this research difficult. An additional limitation of the Weiss study is the use of 
retrospective self-reports, which rely on the memory of study participants, bringing into 
question the reliability of data collected (Weiss et al., 1992).  
Kinnunen, Doherty, Militello, and Garvey (1996) supported the self-medication 
model. This research involved 269 individuals and used several instruments to obtain 
data including; the Center for Epidemiologic Studies Depression Scale (CES-D), the 
Stress Index and Coping Resources Scale, the Health and Withdrawal Symptoms Scale, 
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the Reasons for Smoking Scale, the Attitudes Toward Quitting Scale, and the Fagerström 
Test for Nicotine Dependence. These researchers identified an association between 
depression and smoking as participants reported engaging in smoking to increase energy 
level and improve their mood.  
Lerman, Caporaso, Main, Audrain, and Boyd (1998) investigated cigarette 
smoking from a self-medication model, using the Horn-Waingrow Reasons for Smoking 
Scale (1966), and found that significantly more “negative-affect reduction” smoking (t = 
3.7, p < .0003) occurred in depressed individuals than in non- depressed individuals. An 
additional finding of this study was the dopamine receptor genotype that appears to be 
connected to self-medication, is active in approximately 76% of the population (Lerman 
et al., 1998).   
Kumari and Postma (2005) reviewed research on nicotine that used individuals 
with schizophrenia as the subject group. These authors indicate the rate of nicotine use is 
up to four times as high as seen in the general population. Kumari and Postma examined 
whether the widespread smoking behavior observed in the population of people with 
schizophrenia is a manifestation of common underlying physiology, and if these 
individuals smoke in an attempt to self-medicate. The review of literature conducted by 
Kumari and Postma suggests that smoking in schizophrenia appears to represent an 
attempt to self-medicate some of the cognitive deficits of this disorder. These researchers 
go on to share that the interaction of nicotine with dopaminergic and glutamatergic 
transmitter systems result in improved cognitive functioning in the population studied 
(Kurami & Postma, 2005). These conclusions provide support for self-medication as an 
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explanation of the high incidence of nicotine dependence seen in individuals with 
depression and schizophrenia.  
In 2012, Nakajima and al’Absi, studied negative mood states and smoking. These 
researchers were able to demonstrate that depression, anxiety, anger, and perceived stress 
were able to predict relapse to smoking within 12 months of abstinence in women.  
Findings from this study suggest that women use smoking to manage, or self-medicate, 
mood. 
Biobehavioral. Another model for conceptualizing substance use is though a 
biobehavioral approach. The biobehavioral model does not include components of 
thought and awareness on the part of the substance user who may be self-medicating.  
According to Pomerleau, O., Collins, Shiffman, and Pomerleau, C. (1993) the use of a 
substance results in a reward component regardless of the individual’s mental state. 
However, if a person’s mental state is one of pain or distress, the reward component may 
be more intensive. Therefore, individuals who are experiencing a negative mental state 
likely have an increased response compared to those whose mental status is stable. 
 According to this model, self-medication may develop completely independent of 
thought or intention (Pomerleau et al., 1993). Corrigall, Franklin, Coen, and Clark (1992) 
conducted research on male rats trained to self-administer nicotine on a fixed ratio 
schedule of reinforcement. Post mortem analysis of brain tissue found the effects the 
nicotine had on the transmission of dopamine were reinforcing causing the rats to become 
addicted to this substance (Corrigall et al., 1992).   
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Markou, Kosten, and Koob (1998), investigated the reward and motivational 
properties of substance abuse and depression, which further support the self-medication 
hypothesis. The brain’s reward and motivational systems are compromised in individuals 
with depression and substance abuse (Markou et al., 1998). These researchers indicate 
that drug dependence can be defined as the occurrence of neuroadaptations resulting from 
repeated substance use that has led to and altered behavior. The result of these 
neuroadaptations appears to be a dynamic in which the substance user is positively 
rewarded for use in a subjective manner, such as relieve from a negative mental state. 
Whereas, negative reinforcement occurs when the use of substance is discontinued and 
the withdrawal effects become unpleasant, leading to further use (Hughes, 1993).  
Depression is an example of such negative reinforcement. Research indicates that 
depressive symptomatology increases after a substance user discontinues using (Hughes, 
1993).  
Markou et al. (1998) indicated that for individuals with depression who had an 
onset prior to substance abuse, self-medication might develop “through experimentation 
with several drugs and through the simultaneous use of multiple drugs, people determine 
the drug or drug combination that best normalizes their neurochemical imbalance that is 
expressed behaviorally as depression” (p. 158). These researchers explain self- 
medication in depression that has an onset after the initiation of substance abuse as 
“repeated drug use can be conceptualized as self-medication to counterbalance the 
neuroadaptations produced with chronic drug administration, and thus, used as treatment 
for withdrawal symptomatology” (p. 158).  
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Biophysical. Similar to the biobehavioral model, the biophysical model does not 
rely on intentional behavior or thought. The focus is on the biochemical characteristics of 
the mental health disorder, primarily depression, and the effects of substances on those 
specific characteristics. Therefore, self-medication is an attempt to balance and correct 
the biochemical imbalances associated with a negative affective state (Castaneda et al., 
1989).  
In a study conducted by Castaneda et al. (1989) that included 32 patients 
hospitalized for mental health symptoms and co-occurring substance use, including 
heroin, 100% of the heroin users and the majority of alcohol users acknowledged 
temporary relief from their mental health symptoms after substance use occurred. In spite 
of the substance users recognizing the damaging effects of ongoing use, they persisted to 
use it, which provides an explanation of the biophysical effect that substances have.   
According to Markou et al. (1998) the self-medication hypothesis suggests that 
substance use is intended to make people experiencing depression feel normal by 
reversing some of the neurobiological abnormalities associated with this illness. These 
authors posit that this explanation of the Self-Medication Hypothesis works regardless if 
depression or substance abuse occurs first (Markou et al., 1998).  
Markou et al.’s (1998) theory is supported by the finding that substance use in 
depressed individuals declines when they are treated with antidepressants, whether or not 
the depression occurred prior to, or after, the initiation of substance use. When symptoms 
of depression are reduced, the need to self-medicate is also reduced (Markou et al., 1998).  
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Additional Support for the Self-Medication Hypothesis  
The self-medication hypothesis has been explored outside treatment facilities and 
the usefulness of this theory has been substantiated. Deykin et al. (1987) conducted 
research, using the DIS, on 424 college students, 271 females and 153 males, who were 
diagnosed with an alcohol use and depressive disorder. Retrospective self-reports from 
this population indicate that the likelihood of depression occurring prior to the onset of 
alcohol abuse was the norm with 75% indicating depression came first (Deykin et al., 
1987).  
Additional support for the self-medication hypothesis is demonstrated in the 
results from the National Institute of Mental Health (NIMH) Epidemiologic Catchment 
Area study, which included 9,543 individuals aged 18 to 30 years and utilized the DIS to 
gather data (Christie, et al., 1988). In their exploration into the sequence of mental health 
disorders and substance abuse, 75% reported the development of their affective disorder 
preceding that of their substance abuse. These findings demand special attention due to 
the sampling techniques used in the Catchment Program. Door-to-door sampling occurs 
in non-clinical populations, which sampling bias that comes from surveying only clinical 
populations (Christie et al., 1988). 
Effectiveness of Self-Medication 
  Bibb and Chambless (1986) conducted a study, which applied the MAST on 43 
participants. This study examined the co-occurrence of alcoholism and agoraphobia and 
found that 10-20% of individuals diagnosed with agoraphobia meet criteria for a 
diagnosis of alcohol dependence. These researchers also conducted a comparison 
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between alcohol dependent and non-alcohol dependent agoraphobics, finding that those 
with alcohol dependence had a higher incidence of depression and social phobia. Of the 
alcohol dependent population, 91% reported their primary motivation for substance use 
was aimed at reducing distressing symptoms, primarily anxiety, compared to 43% of non-
dependent population reporting substance use for this reason (Bibb & Chambless, 1986).  
The research conducted by Bibb and Chambless (1986) also reveals that self-
medication is not effective in the long-term. In fact, Bibb and Chambless share that 
substance use appears to increase the very symptoms it is intended to relieve. According 
to Weiss et al. (1992) there is evidence to support that self-medication is effective at 
relieving symptoms in the short-term which contributes to maintain the behavior of self-
medication. 
Aneshensel and Huba (1983) conducted a study, which included 742 adults and 
spanned over a one-year period of time. Four symptom scales including; the CES-D, the 
Psychiatric Epidemiology Research Interview (PERI), the General Well-Being 
Questionnaire, and a death-ideation scale were used. Results from the study suggest that 
heavy drinking does appear to increase depression levels. However, this effect does not 
seem to appear until approximately 12 months after the heavy drinking begins. 
Additionally, results of this study suggest as depressive symptoms increase, impulsive 
use increases, which leads to further increase in symptoms and eventual uncontrolled use 
(Aneshensel & Huba, 1983).                                                                                             
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Summary 
The self-medication hypothesis provides a valid theoretical framework to explore 
the connection between mental health disorders and relapse to alcohol use. A gap exists 
in the literature examining the possibility of mental health disorders being a predictor of 
relapse in previously detoxified patients. This study may help to bridge this gap and 
provide useful information related to the importance of identifying individuals with co-
occurring disorders to ensure they are referred to the most appropriate aftercare services 
following alcohol detoxification. The next chapter explains how the study was conducted, 
including the research design, description of the participants, and description of the study 
site.  
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Chapter 3:  Methodology 
Introduction 
The purpose of this exploratory study was to examine depression, anxiety, 
psychosis and personality disorders, as identified by three different instruments; the 
PHQ-9; the MMS; and the MCMI-III, as predictors of relapse in individuals that have 
been previously detoxified from alcohol. The criterion variable in this study was number 
of days to relapse, within the first 90 days following initial detoxification, resulting in 
readmission for alcohol detoxification.  
This was a quantitative study and utilized a nonexperimental design to answer the 
research questions. The site for the study was a public behavioral health facility, located 
in central Wisconsin. Participants were drawn from the detoxification units located within 
this facility.  
Specific information was provided, by staff from the facility where the research 
was conducted, to this researcher including; demographic information, alcohol 
detoxification events, and scores from instrumentation used. Data collection began after 
approval for the study was received from the Institutional Review Board (IRB approval 
number: 08-06-14-0084988) and continued until a sample size of 45 was achieved.  
 The research that was conducted for this dissertation was a clinical investigation 
utilizing the substance use disorder first approach. This method was selected, as the target 
population for this study was individuals who relapse to alcohol use, requiring 
detoxification services within 90 days of being discharged from a detoxification service.  
The standard benchmark used by the Centers for Medicare & Medicaid Services (CMS) 
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is the 30-day readmission rate; however the facility the study will occur within 
experiences almost a doubling of the readmission rate within the 90-day time frame.  
Therefore 90-day readmission data will be utilized for this study in order to acquire 
adequate data and meaningful results. Witkiewitz (2011) supported the use of a 90 day 
time frame, indicating that the largest percent of relapse is likely to occur within this time 
frame. The study population will be examined to determine if the presence of mental 
health disorders can predict an increased risk for relapse. 
The design, methodology, and validity of the research study are reviewed in this 
chapter. Each tool selected for use in the study, as well as the validity of each, is 
described below. 
Research Design and Rationale 
Study Variables 
Predictor variables including depression, anxiety, psychosis, and personality 
disorders, were collected and measured using validated instruments, which included the 
MMS, the MCMI- III, and the PHQ-9. The criterion variable, number of days to relapse, 
within the first 90 days following initial detoxification, resulting in readmission for 
alcohol detoxification, was collected by monitoring the daily census of the detoxification 
units and identifying admissions. The daily census was monitored 90 days post discharge 
from detoxification services for each subject to obtain actual number of days to relapse. 
Data collected was analyzed using the statistical procedure of bivariate linear regression 
analysis.   
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Design                                                                                                                                   
 A nonexperimental design was utilized in the study to answer the research 
questions. Bivariate linear regression analysis was conducted utilizing SPSS 21 software.  
Identifying which of the variables might be able to predict the criterion variable was the 
intended outcome of conducting a regression analysis for each potential predictor 
variable. 
This design choice is consistent with past research using the theoretical 
framework of the self-medication hypothesis as described in the literature reviewed in 
Chapter 2 of this dissertation. The purpose of using such a design was intended to add to 
the research base, providing new information which has the potential of expanding 
knowledge in the field of co-occurring disorders.   
Time 
This study covered a time span that extended 90 days after the final participant 
was enrolled, beginning August 6, 2014 and extending through November 22, 2014.  
Ninety days post final participant enrollment was based on the study’s definition of 
relapse.  
The time period of 90 days was selected as the duration in which to measure 
relapse, as according to data from the facility the study occurred within, the rates of 
relapse resulting in readmission for detoxification services are measured at 30, 90, and 
180 day intervals. Relapse rates at these time points for 2013 were 9.1%, 20.6%, and 
26.2% respectively.    
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Methodology 
Population 
Participants for the study were obtained from a public behavioral health facility 
that provides detoxification services, located in central Wisconsin. Data collection began 
after IRB approval and extended until the required sample size was attained. All 
participants were least 18 years of age, approximately 3/4 of the population was male and 
1/4 was female, the vast majority of clients are Caucasian. Central Wisconsin is fairly 
isolated and has limited diversity.  
Sampling and Sampling Procedures 
The instruments used in the study were adopted by the facility as standard 
practice, prior to the study beginning. The substance abuse counselors’ employed at the 
setting facilitated the completion of the instruments. Instruments were presented to 
patients for completion during the discharge planning process. Completing the 
instruments near the end of a patient’s stay provided assurance that intoxication was not a 
confounding factor.    
Inclusion criteria. All patients, male and female, who were admitted to the 
detoxification units during the study period, were attempted to be included in the study.  
Those who were able to comprehend the English language, completed all of the study 
instruments, and scored positive for having a mental health disorder were included in the 
study data provided to this researcher.  
Exclusion criteria. Participants were required to comprehend the English 
language, as study instruments were not be available in other languages. Individuals who 
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did not meet criteria for having a mental health disorder, based on scores from study 
instruments were excluded from the study. Individuals who relapsed and returned to the 
detoxification unit multiple times during the designated study period were excluded from 
the data after their first participation, to ensure that each participant was counted only one 
time.   
 Power analysis. A minimum of 34 participants were required for the study as 
determined by conducting an a priori power analysis using PASS-13 Sample Size 
Software obtained from the NCCS Statistical Software website found at www.ncss.com.  
Specific criteria used to determine sample size included using a 1-tailed test, a large (.50) 
effect size, a 0.05 alpha level, and a power level of 0.95. Faul et al. (2009) recommend 
these parameters when using the statistical test of bivariate regression analysis. To ensure 
an adequate sample size, data for 45 individuals was provided to this researcher from the 
facility where this study was conducted.  
Procedures for Recruitment, Participation, and Data Collection 
Recruitment and participation. The site for the study was a public behavioral 
health facility, located in central Wisconsin. The instruments used in the study were 
adopted by the facility as standard practice, prior to the study beginning. The substance 
abuse counselors’ employed at the setting provided patients with an overview of the three 
instruments used to measure the predictor variables and the actual instruments to 
complete prior to discharge. The three instruments used to measure the predictor 
variables included the MMS, the MCMI III, and the PHQ-9. A data file containing basic 
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demographic information, previous detoxification status, and study instrument results 
was provided to this researcher by officials at the research site.   
 Informed consent. Considering the instruments used in the study were adopted as 
standard practice, at the request of this researcher, by the facility the research was 
conducted in prior to the initiation of the study, informed consent was not required. The 
facility staff administered the three instruments used to measure the predictor variables 
and provided the researcher with the results of the instrumentation used. Results were 
provided using two choices, positive or negative. Positive, meaning that criteria were met 
for the presence of having predictor variable, and negative, meaning that criteria were not 
met for the presence of having the predictor variable. All information provided to this 
researcher related to study participants included only pseudo-identifiers, therefore 
confidentiality was not compromised. 
Data was collected using three different instruments: the MMS, the MCMI-III, 
and the PHQ-9, which are all described in detail in the following section. All instruments 
were completed by the participants and are self-report measures. Instruments were 
provided to participants during the discharge-planning meeting, after they were no longer 
intoxicated. 
 The criterion variable, number of days to relapse, within the first 90 days 
following detoxification, resulting in readmission for alcohol detoxification, was 
collected by monitoring the daily census of the detoxification units and identifying 
admissions. The daily census was monitored for study participant relapses, for a period of 
90 days from discharge from the initial detoxification event.   
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Instrumentation and Operationalization of Constructs 
 The MMS, the MCMI-III, and the PHQ-9  were selected to measure the predictor 
variables of; depression, anxiety, psychosis, and personality disorders, in this study as 
together they provide a comprehensive screening for mental health disorders including 
both major mental disorders, and personality disorders.   
Modified Mini Screen (MMS) 
The MMS was developed by the New York State Practice Improvement 
Collaborative, under a grant from the United States Department of Health and Human 
Services, Substance Abuse and Mental Health Services Administration, Center for 
Substance Abuse Treatment (New York State Office of Alcoholism & Substance Abuse 
Services, 2001). The MMS was utilized in the current study to identify mental health 
disorders. The MMS is a 22-item questionnaire that takes approximately 15 minutes to 
administer and consists of questions and threshold criteria found in the Diagnostic 
Statistical Manual IV (DSM-IV0, the Structured Clinical Interview for Diagnosis (SCID) 
and the Mini International Neuropsychiatric Interview (M.I.N.I.) (Alexander, Layman, 
Haugland, & Tang, 2003).    
The screen is divided into three sections, which include the three major categories 
of mental health disorders; mood disorders, anxiety disorders, and psychotic disorders.  
Scoring of the MMS is straightforward and simple, with a Yes response converting to 1 
point, and a No converting to 0 points. The clinician adds all the positive (yes) responses 
to obtain a total score, which can range from 1 to 22 points (Alexander et al., 2003).  
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Recommendations for using the MMS include three different cutpoints, each 
identifying a different plan of action for the client. Cutpoint 1 is ≤ 5, with no further 
action required. Cutpoint range 2 is between 6 and 9, and suggests a treatment team 
decision should occur regarding need for a mental health assessment. Cutpoint 3 is any 
one the following:  a score of  ≥ 10, a positive response to question #4 which addresses 
suicidality, or a positive response to both question #14 and #15 as they target post-
traumatic stress disorder. Individuals who score in Cutpoint 3 should be referred for a 
mental health assessment. For the purpose of this study, those who scored in the Cutpoint 
2 and Cutpoint 3 range were considered to be positive for a mental health disorder 
(Alexander et al., 2003).   
Validity. Validity of the MMS has been tested, with two primary studies showing 
up in the literature; the New York State Practice Improvement Collaborative (PIC) 
compiled by Brandau, Alexander, and Haugland in 2001 (New York State Office of 
Alcoholism & Substance Abuse Services, 2001), and the Mental Health Screening in 
Addiction, Corrections and Social Services Settings validation study by Alexander, 
Haugland, Lin, Bertollo, and McCorry (2008). 
New York State Practice Improvement Collaborative (PIC) validation study. To 
ensure that all clients with co-occurring disorders entering behavioral health treatment 
would be identified and assessed, the New York State PIC sponsored a validation study, 
as part of the ongoing collaboration between the Office of Alcohol and Substance Abuse 
Services (OASAS) and Office of Mental Health (OMH). This purpose of this study was 
to validate two screening instruments, the MMS, for use in the OASAS system, and the 
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Dartmouth Assessment of Life Inventory 8 (DALI), for use in the OMH system of care  
(New York State Office of Alcoholism & Substance Abuse Services, 2001), 
The two agencies came together and sought out the Nathan Kline Institute’s 
Center for the Study of Issues in Public Mental Health (NKI) to conduct the study. All 
seventeen OASAS sites, throughout the state of New York were included in the study, in 
addition to a New York City shelter and a county jail in a New York City suburb. The 
OASAS sites included a variety of settings including; two addiction treatment centers, 
two methadone treatment programs, three therapeutic communities, nine medically 
supervised outpatient programs, and one jail-based medically supervised outpatient 
program. Overall, 485 clients were administered the MMS. Additionally, all clients 
participated in an interview, which utilized the Structured Clinical Interview for 
Diagnosis (SCID). The validation criterion was the presence of a mood, anxiety, or 
psychotic disorder based on the SCID, which was administered by interviewers 
experienced in working with this tool (New York State Office of Alcoholism & 
Substance Abuse Services, 2001). 
 The validation study confirmed the value of the MMS as a screening tool for use 
by OASAS providers with an overall accuracy of rate of .70 to .74, depending on the cut-
point employed to define a positive result. The instrument performed equally well across 
both genders, various ethnic and racial groups, and across all modalities (New York State 
Office of Alcoholism & Substance Abuse Services, 2001). 
Mental Health Screening in Addiction, Corrections and Social Service Settings 
validation study. Alexander et al. (2008) conducted a MMS validation study on 476 
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individuals in chemical dependency treatment settings, jails, shelters, and outreach 
settings. This study also conducted validation interviews on all participants, utilizing the 
SCID. Researchers used Receiver Operating Characteristic (ROC) curve analysis to 
determine the optimal range of cut points for identifying mental health problems; 
calculate overall accuracy, sensitivity, specificity; and identify positive and negative 
predictive values for the MMS (Alexander et al., 2008). 
Forty three percent of the sample met criteria for a DSM-IV diagnosis of anxiety, 
mood or psychotic disorder. At cutpoints of 6 to 9, the sensitivity of the MMS ranged 
from .63 to .82, its specificity ranged from .61 to .83, and its overall accuracy ranged 
from .70 to .75, which aligns with the results of Brandau et al. study conducted several 
years earlier. At these cutpoints, the MMS screen performed equally well for men and 
women, and for African Americans and Caucasians (Alexander et al., 2008). Alexander 
et al. concluded the MMS performs well in naturalistic chemical dependency treatment 
settings, jails, shelters, and street outreach programs across gender and ethnic groups, and 
can provide a useful tool in service systems for persons with co-occurring mental health 
and substance abuse problems. The MMS was used to identify anxiety, depression, and 
psychosis in the present study. 
Reliability. According to Alexander et al. (2003), validation efforts indicate the 
MMS demonstrates three indices of reliability; internal consistency, test re-test, and inter-
rater reliability, that range from good to excellent. These three indices will be reviewed in 
further detail below. 
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Internal consistency and test-retest. Cronbach’s alpha was calculated to evaluate 
the internal consistency of all 22 items included in the MMS (α = .9) (Alexander et al., 
2003). These results indicate that the MMS has a high level of internal consistency.   
Test-retest reliability was evaluated to identify if the MMS is reliable over time. Forty 
individuals who completed the MMS were invited to take the MMS again within two 
weeks of the original MMS administration. Retest results were not normally distributed; 
therefore a Spearman’s rho was used to calculate test-retest reliability. The MMS scores 
at the first administration (𝑋 = 5, SD = 5), indicating that the MMS is a reliable 
instrument (rho = .71, p < .001) (Alexander et al., 2003). 
Interrater reliability. The MMS is a self-report measure; therefore raters are those 
who the measure is being used on. According to Alexander et al. (2003), for individuals 
in chemical dependency treatment, sensitivity of the MMS in predicting a need for further 
mental health assessment ranged from 63% - 82%, and specificity for correctly assessing 
no need for an assessment referral ranged from 61% - 83%, which represents  good 
reliability. 
Millon Clinical Multiaxial Inventory-III (MCMI-III) 
The MCMI-III was developed by Theodore Millon, Carrie Million, Roger Davis, 
and Seth Grossman and is intended to be an evolving assessment tool, to be refined and 
strengthened as needed based on advances in theoretical logic, research data, and 
professional nosology (Millon, Millon, Davis, & Grossman, 2009). The MCMI-III is a 
175-item self-report inventory of personality that provides information on both clinical 
syndromes and personality disorders. This inventory consists of 14 personality disorder 
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scales, 10 clinical syndrome scales, 5 correction scales, and 42 Grossman personality 
facet scales. The personality disorder scales include; schizoid, avoidant, dependent, 
histrionic, narcissistic, antisocial, aggressive/sadistic, compulsive, passive-aggressive, 
self-defeating, and depressive. Severe dysfunctional variants include; schizotypal, 
borderline, and paranoid. Anxiety disorder, somatoform disorder, bipolar disorder, 
dysthymic disorder, alcohol dependence, drug dependence, thought disorder, major 
depression, delusional disorder, depressive personality, and post-traumatic stress disorder 
make up the clinical syndrome scales. The Correction scales detect random responses, 
and the Grossman scales are based on Seth Grossman’s theories of personality and 
psychopathology (Millon, T., Millon, C., Davis, & Grossman, 2009).  
Test results may be considered invalid based on a number of different response 
patterns on the modifying indices. The Disclosure scale is the only scale in the MCMI-III 
in which the raw scores are interpreted and in which a particularly low score is clinically 
relevant. A raw score above 178 or below 34 is considered to not be an accurate 
representation of the patient's personality style as they either over-or under-disclosed and 
may indicate questionable results (Millon et al., 2009).  
The invalidity index is a measure of random responding, ability to understand 
item content, appropriate attention to item content, and as an additional measure of 
response style. The scale is very sensitive to random responding. Scores on this scale 
determine whether the test protocol is valid or invalid. A base rate score of 75 or greater 
on the desirability or debasement scales indicate that the examiner should proceed with 
caution (Millon et al., 2009)  
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For the personality and clinical syndrome scales, base rate scores of 75-84 are 
taken to indicate the presence of a personality trait, or the presence of a clinical 
syndrome. Scores of 85 or above indicate the persistence of a personality trait or a 
clinical syndrome (Millon et al., 2009). 
Validity. The MCMI-III has undergone three different stages of validation: 
theoretical-substantive, internal-structural, and external-criterion (Millon et al., 2009).  
This three-stage model is often referred to as the tripartite model of test construction and 
synthesizes the strengths of each development phase by rejecting items that are found to 
be deficient in specific respects. This process ensures that the final scales of an inventory 
do not optimize one particular parameter of test construction; instead, together satisfy 
multiple requirements which then leads to increased generalizability of the end product 
(Millon et al. 2009). 
Theoretical-substantive stage. During the theoretical-substantive stage, items for 
each different syndrome were identified that adhere to criteria set forth by the Diagnostic 
and Statistical Manual of Mental Disorders. This stage used a deductive approach and 
involved developing a large pool of items; the number of items was reduced based on a 
rational approach according to the degree to which they fit the theory, as well as 
elimination of items based on simplicity, grammar, content, and relevance to the scale 
(Millon et al., 2009). 
Internal-structural stage. During the internal-structural stage, the items that made 
it through the theoretical-substantive stage underwent analysis to ensure internal 
consistency. Internal consistency is the extent to which the items on a scale generally 
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measure the same thing. Items that had higher correlations with scales for which they 
were not intended were re-examined against theoretical criteria and reassigned or 
dropped all together (Millon et al., 2009). 
External-criterion stage. The final validation stage was assessed by examining 
the items in terms of their ability to discriminate among clinical groups rather than 
between clinical groups and normal individuals. According to Millon et al. (2006), in 
every generation of the MCMI, the external-criterion stage of validation has emphasized 
data in which target diagnostic groups were contrasted with a population of 
representative, but undifferentiated, psychiatric patients. Using a population with mental 
health disorders, rather than a normal population, improves the discriminative efficiency 
of scales and thereby heightens differential diagnosis (Millon et al., 2009). 
The MCMI-III was used to confirm or negate the presence of depression, anxiety, 
psychosis, and personality disorders. The MCMI-II/III Interpretive System software was 
used by the facility to analyze data and generate interpretive reports on the data entered 
from the MCMI-III tests that are completed.  Individuals with base rate scores of 75 and 
above on the predictor variables; depression, anxiety, psychosis, or personality disorders 
were considered positive for the presence of such variables.                               
 Reliability. The MCMI-III has demonstrated reliability based on internal 
consistency and test-retest results. Together, internal consistency and test-retest results 
have demonstrated the reliability of the MCMI-III. 
Internal consistency. Internal consistency was appraised through examining the 
consistency of the scales used in the MCMI-III using Cronbach’s alpha, which is the 
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mean of all possible split-half reliabilities. Internal consistency results for the clinical 
scales range from .66 - .90, with major depression demonstrating the highest level of 
internal consistency (α = .90). Internal consistency was based on the cross-validation of 
398 tests (Millon et al., 2009). 
Test-retest reliability. According to Millon et al. (2009) test-retest reliability is as 
important as internal consistency. To examine test-retest reliability, 87 subjects were 
readministered the MCMI-III five to fourteen days after the initial administration. Data 
from the second administration were used to estimate retest stability of the MCMI-III 
scales. Results range from .82 to .96, with a median stability coefficient of .91. This 
result suggests that MCMI-III results are very stable over short periods of time (Millon et 
al., 2009). 
Patient Health Questionnaire (PHQ-9) 
The Primary Care Evaluation of Mental Disorders (PRIME-MD) was an 
instrument developed and validated by Kurt Kroenke and Robert Spitzer in the early 
1990s with the purpose of efficiently diagnose five of the most common types of mental 
health disorders including; depression, anxiety, somatoform, alcohol, and eating disorders 
(Kroenke & Spitzer, 2002). The PHQ-9 is a self-administered version of the PRIME-MD 
instrument designed to detect depression, as well as grade depressive symptom severity 
(Martin, Rief, Klaiberg, & Braehler, 2006).                                                                                                                
 The PHQ-9 consists of the nine criteria, on which the diagnoses of DSM-V 
depressive disorders are based, and is able to provide provisional depressive diagnoses.  
Major depression is diagnosed if five or more of the nine depressive symptom criteria 
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have been present at least half the days over the past two weeks, and one of the symptoms 
is depressed mood or anhedonia (Kroenke & Spitzer, 2002). 
As a severity measure, the PHQ-9 score ranges from 0 to 27, as each of the 9 
items can be scored from 0 (not at all) to 3 (nearly every day). Cutpoints of 5, 10, 15, and 
20 represent the thresholds for mild, moderate, moderately severe, and severe depression, 
respectively. A single screen cutpoint of 10 or greater was used in this study, as 
demonstrated sensitivity and specificity for major depression at this cutpoint is 88% 
(Kroenke & Spitzer, 2002). 
Validity. The diagnostic validity of the 9-item PHQ-9 was established in studies 
involving 8 primary care and 7 obstetrical clinics. PHQ-9 scores of 10 or greater had a 
sensitivity of 88% and a specificity of 88% for Major Depressive Disorder. According to 
Kroenke and Spitzer (2002), reliability and validity of the tool have indicated it has sound 
psychometric properties. Criteria validity was established by conducting 580 structured 
interviews by a mental health professional. Results from these interviews showed that 
individuals who scored high of 10 or greater on the PHQ-9 were between 7 to 13.6 times 
more likely to be diagnosed with depression by the mental health professional. On the 
other hand, individuals scoring 4 or below on the PHQ-9 had a less than a 1 in 25 chance 
of having depression (Kroenke & Spitzer, 2002).                                                       
 Martin et al. (2006) conducted a validity study of the PHQ-9 with the main aim 
the purpose of assessing the validity of the PHQ-9 in the general population. While there 
was already a significant body of evidence that supports its validity in medical settings, 
no data had been available on its validity in the general population. This study 
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consistently found a strong positive association between depression and disability, and a 
strong negative association between depression and functional health status across the 
PHQ-9 diagnostic groups.  
These results provide strong support for the ability of the PHQ-9 to discriminate 
depressed from non-depressed individuals. The PHQ-9 was used to identify the presence 
of depression in participants involved in the study.   
Reliability. The internal reliability of the PHQ-9 was examined by mental health 
professionals conducting validation interviews on 580 subjects within 48 hours after 
completing the PHQ-9 instrument. Agreement between the PHQ-9 diagnoses and the 
mental health professional’s diagnoses was examined. The internal reliability of the 
PHQ-9 was excellent with a Cronbach’s alpha (α = 0.84). Additionally, the mean scores 
were almost identical for the PHQ-9 (M = 5.08) and the mental health professionals 
validation interview (M = 5.03) (Kronke, Spitzer, & Williams, 2001). 
Threats to Validity 
In this study, it is important to note that a convenience sample was utilized, 
therefore any speculative generalizations that are made, must be done so considering only 
similar populations. Also, the lack of random assignment in the non-experimental design 
method may present concerns in terms of internal validity. 
 Limitations of each of the instruments used in this study also pose potential 
threats to the validity of this study. Although, the instruments used in this study have 
been thoroughly researched and tested, and determined to be valid, studies that use self-
report measures have potential validity concerns (Kroenke & Spitzer, 2002). Individuals 
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may over-report or under-report the severity or frequency of symptoms in order to 
maximize or minimize their problems. Readers of this research must keep these 
limitations in mind to ensure that results are not generalized or interpreted beyond the 
scope intended. 
The MMS is a screening tool, and as such, may either under-identify or over-
identify the condition it is designed to detect. When the MMS is used, the likelihood of 
identifying individuals who have a mental health disorder increases. However, the 
potential exists to incorrectly identify some individuals as exhibiting signs or symptoms 
of a mental health disorder when such a disorder is not present.   
The MCMI-III was normed based entirely on clinical samples rather than the 
general population. The diagnostic scale cutoffs and profile interpretations within the 
MCMI-III are oriented to the majority of individuals who take the inventory. Therefore, a 
diminished degree of diagnostic and interpretive validity occurs for individuals who score 
on the low and high ends of the scales. There is not a distinct division between Axis I 
(major mental health disorders) and Axis II (personality disorders) phenomena, which is 
an additional limitation of the MCMI-III.  Efforts have been made to rephrase the MCMI-
III items from one version to the next to more clearly separate clinical phenomena from 
trait character phenomena; however the potential exists for occasional personality 
disorders misidentification (T. Millon, Davis, C. Millon, & Grossman, 2009).                                                                                                                                
 The PHQ-9 was developed and normed on patients presenting in primary care 
settings and has not been thoroughly examined for administration to patients with mental 
health disorders (Inoue et al., 2012). Tools identified for use in this study have been 
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selected to be used in combination, in an attempt to minimize the limitations of each of 
the tools independently. 
Ethical Procedures 
Access. The facility where the study took place was interested in this research 
occurring within their organization as a part of their ongoing quality improvement 
program. All data that was collected and reported included only pseudoidentifiers to 
protect the privacy of participants. 
Treatment of human participants. The overall intent of this research was to 
improve the human and social conditions for people with co-occurring disorders. Thus, it 
may be used to assist researchers in determining ways to improve the health and well-
being of individuals with co-occurring disorders.  
The intent of this research was to produce useful results and increase knowledge 
in the field of alcohol addiction and co-occurring disorders. The exclusion criteria for this 
study was minimal, therefore it is expected to demonstrate equitable participant selection.  
No risks have been identified for participants of the proposed study. Informed consent 
was not required for this study, as the research instruments were adopted by the facility 
prior to the study beginning. 
 Treatment of data. Pseudoidentifiers, rather than personal identifiers, were 
utilized to protect confidentiality. All data related to this study was provided to this 
researcher in a data file and will be maintained for a minimum of 5 years after completion 
of this dissertation.  
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Study conducted within researches own work environment. The research 
study was conducted within my own work environment, however I had no authority over 
the programs or staff the study was conducted in. The study environment was within the 
Inpatient Service Line at the facility, where both detoxification programs exist. My role is 
within the Outpatient Service Line, which includes no involvement in the oversight or 
accountability for the detoxification programs.   
                                                Summary                                                                                                    
 Together, results from the MMS, the MCMI-III, and the PHQ-9 were used to 
identify if, and which type of mental health disorders exist in study participants, and if a 
relationship exists between mental health disorders and repeated alcohol detoxification 
events. 
The scientific method of inquiry was utilized in this study to identify predictors of 
relapse in patients detoxified from alcohol.  The study was designed to answer the 
research questions and test the hypotheses based on the theoretical framework of the self-
medication hypothesis. The self-medication hypothesis suggests that people with mental 
health disorders use alcohol and other substances to self-medicate the symptoms they 
experience. The next chapter, Chapter 4, describes the actual study conducted, including 
data collected, analysis of the data, and results of the study. 
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Chapter 4:  Results 
The purpose of this quantitative study was to identify predictors of relapse in 
patients detoxified from alcohol. The potential predictor variables selected for this study 
included depression, anxiety, psychosis, and personality disorders as measured by three 
different instruments (PHQ-9, MMS, and MCMI-III). The criterion variable involved in 
this study was number of days to relapse, within the first 90 days following initial 
detoxification, resulting in readmission for alcohol detoxification.  
The research questions were:  
1. Does depression, as measured by the PHQ-9, significantly predict relapse 
 among individuals within 90 days following  alcohol detoxification?   
2. Does depression, as measured by the MMS, significantly predict relapse among 
 individuals within 90 days following alcohol detoxification?  
3. Does depression, as measured by the MCMI-III, significantly predict relapse 
 among individuals within 90 days following alcohol detoxification?  
4. Does anxiety, as measured by the MMS, significantly predict relapse among 
 individuals within 90 days following alcohol detoxification?  
5. Does anxiety, as measured by the MCMI-III, significantly predict relapse 
 among individuals within 90 days following alcohol detoxification?  
6. Does psychosis, as measured by the MMS, significantly predict relapse  among 
 individuals within 90 days following alcohol detoxification?  
7. Does psychosis, as measured by the MCMI-III, significantly predict relapse 
 among individuals within 90 days following alcohol detoxification?  
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8. Do personality disorders, as measured by the MCMI-III, significantly predict 
 relapse among individuals within 90 days following alcohol detoxification?   
  This chapter includes a description of the data collection process, setting, 
demographics, data analysis, evidence, results, and summary. 
Data Collection 
Initial data collection for this study began on August 6, 2014, and extended 
through August 22, 2014. This period of time was required to achieve the required 
sample size of 34, identified by conducting an a priori power analysis using PASS-13 
Sample Size Software obtained from the NCCS Statistical Software website found at 
www.ncss.com. To ensure that an adequate sample size was achieved, considering some 
individuals may have needed to be excluded due to the possibility of them not fully 
completing study instruments, eleven additional individuals were involved in the study, 
for a total of 45 individuals. However, the data file provided to this researcher, included 
results on all study instrumentation, from all 45 individuals, thus all were viable for 
inclusion in the study. Therefore, all 45 individuals were included in the data analysis.   
Instrumentation included a standardized screening instrument (MMS), a brief 
depression assessment (PHQ-9), and a test that identifies Axis I & Axis II disorders 
(MCMI-III). Participants completed the instruments after they had detoxified from 
alcohol, and before they were discharged. This time frame was identified to ensure that 
intoxication was not a confounding factor in the study. All three instruments are self-
report measures. Scoring of completed instruments was performed by facility staff.    
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If a positive score, identified by a score of; 10 or greater on the PHQ-9, 6 or 
greater on the MMS, and 75 or greater on the MCMI, for any of the predictor variables, 
occurred, the following information was provided to me, the researcher, by facility staff; 
patient identification number, age, gender, positive or negative status for previous alcohol 
detoxification episodes, and positive or negative status for each of the three test 
instruments. The next step involved monitoring the daily census of the detoxification 
services to identify readmissions of the study population for a period of 90 days 
following each participant’s initial admission for detoxification. The actual number of 
days between discharge from detoxification services to relapse resulting in readmission 
for detoxification services was collected by monitoring the daily census. Data collection 
was completed 90 days following the final participants’ admission for detoxification and 
concluded on November 22, 2014. 
Setting 
The site for the study was a public behavioral health facility, located in central 
Wisconsin. Participants were drawn from the detoxification units located within this 
facility. The instruments used in the study were adopted by the facility as standard 
practice, prior to the study beginning.  The substance abuse counselors’ employed at the 
setting facilitated the completion of the instruments. Test instruments included; MMS, 
MCMI-III, and PHQ-9.   
Demographic Characteristics of the Sample                                               
The current study included data from 45 individuals from a public behavioral  
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health facility, located in central Wisconsin. Following appropriate approval to conduct 
research from the Institutional Review Board (IRB) of Walden University, the 
participants were identified based upon the following criteria; admission for alcohol 
detoxification services, successful completion of all three test instruments, and attaining a 
positive score for a least one of the predictor variables; depression, anxiety, psychosis, or 
personality disorder, on at least one of the test instruments. Requiring a positive score for 
at least one of the predictor variables was required, as the purpose of the study was to 
identify predictors of relapse in patients detoxified from alcohol. Only those individuals 
that met all of the criteria were included in the study. 
Of the 45 participants, 12 were female (26.7%) and 33 (73.3%) were male. The 
facility the study was conducted at indicated the typical population admitted for 
detoxification is approximately 25% female and 75% male. Therefore, it was anticipated 
that the study population would be closely aligned with this assumption. Table 2 provides 
a summary of the study samples gender, which supports the assumption regarding gender 
mix. 
Table 2 
 
Gender Frequency and Percent of Study Population (N = 45) 
 
Gender Frequency Percent 
Male 33 73.3 
Female 12 26.7 
Total 45 100.0 
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The mean age of the study sample was 44.42 (SD = 11.13), and participants 
ranged in age from 21 to 65 years. Table 3 presents the age break out, by gender, of the 
study population. Typical census data is presented in 10 year increments, which is how 
the data is broken down. The youngest subject was 21 and the oldest was 65, therefore 
the data starts and stops at these points.     
Table 3 
 
Age and Gender of Study Population (N = 45) 
 
Age Males Females Total 
21-29 2 3 5 
30-39 6 1 7 
40-49 16 3 19 
50-59 5 4 9 
60-65 4 1 5 
 
Only two participants were of an ethnicity other than Caucasian. One individual 
was Asian and the other Hispanic. Neither of the non-Caucasian participants were 
readmitted for alcohol detoxification services during the research time parameter of 90 
days. Ethnic characteristics of the study sample are presented in Table 4. 
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Table 4 
 
Ethnic Characteristics of  Study Sample (N = 45) 
 
Characteristics Number Percentage 
Caucasian/White 43 95.56% 
Hispanic/Latino 1 2.22% 
Asian 1 2.22% 
 
 Twenty-seven of the 45 participants involved in this study, had been provided 
detoxification services, at least one time, prior to this study beginning. Of the 27 
individuals that had received previous detoxification services, 20 of these individuals 
(74.07%) were readmitted within 90 days from their initial detoxification admission for 
the present study, which means that this was at least the third time they had been 
provided detoxification services. This indicates a recurrent pattern for this sub-population 
group (44.44% of total study population). 
 Twenty four of the 45 individuals (53.33%) involved in this study relapsed (M = 
6.49, SD = 12.11) within the identified 90 day time frame, thus were readmitted for 
subsequent detoxification services. This suggests that the study population is a very 
chronic population that may benefit from intensive aftercare services. Of clinical 
importance, all individuals admitted for detoxification services are screened for suicide 
risk and immediate intervention occurs if a positive screening occurs. Psychiatry and 
social work services are available and utilized when moderate to high suicide risk is 
identified. 
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Results 
Data Analytic Strategy 
 Data analyses for this study were conducted using SPSS 21 software (IBM, 2012).  
This researcher conducted an analysis of data, collected at the request of this researcher, 
by staff from the facility the study was conducted in. Eight simple bivariate regression 
analyses were conducted, one for each selected predictor variable, to explore whether or 
not each predictor variable was able to adequately predict the criterion variable, relapse, 
among patients previously detoxified from alcohol.  
Data Preparation Prior to Analyses 
 All data elements, including results from three test instruments, demographic 
information, and relapse information, were combined into a single dataset using an Excel 
spreadsheet. No data was excluded from analyses as all data provided to this researcher 
was complete, therefore all data provided by the facility was viable for the study.                                                                                                                                
Analyses 
Eight bivariate linear regressions were conducted using the linear regression 
function in SPSS. Each predictor variable, identified as independent variables in SPSS, 
was correlated with the criterion variable, identified as the dependent variable in SPSS, to 
run the analyses. The purpose of running the bivariate linear regressions was to determine 
if any of the predictor variables; depression, anxiety, psychosis, and personality 
disorders, as identified by the three instruments used: PHQ-9, MMS, and MCMI-III, were 
able to significantly predict the criterion variable, number of days to relapse, within the 
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first 90 days following initial detoxification, resulting in readmission for alcohol 
detoxification.                                                            
Alpha level applied in the study. An alpha of 0.05 was selected for the study 
based on Field (2000) and Gravetter and Wallnau (2007), who suggest that 0.05 is the 
acceptable probability value in the social sciences. An alpha level of 0.05 is conventional 
practice that has become the accepted standard in the social sciences (Gravetter & 
Wallnau, 2007). 
Regression Models 
 Bivariate Linear Regression. This subsection deals with the contribution of each 
of the predictor variables to the prediction of the criterion variable. The criterion variable, 
number of days to relapse within the first 90 days following initial detoxification, 
resulting in readmission for alcohol detoxification was correlated with each of the four 
predictor variables based on each of the three test instruments, resulting in eight bivariate 
linear regressions being conducted. These eight regressions were needed to answer the 
eight research questions. The eight linear regressions used the following predictor 
variables:  a) depression as measured by the PHQ-9, b) depression as measured by the 
MMS, c) depression as measured by the MCMI-III, d) anxiety as measured by the MMS, 
e) anxiety as measured by the MCMI-III, f) psychosis as measured by the MMS, g) 
psychosis as measured by the MCMI-III, and h) personality disorders as measured by the 
MCMI-III. The results from each of these regression analyses follow.   
 Evaluating the model. The ‘model’ refers to the specific variable that was used 
as a predictor of the criterion variable. In this study the predictor variables refers to 
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depression as measured by the PHQ-9; depression as measured by the MMS; depression 
as identified by the MCMI-III; anxiety as measured by the MMS; anxiety as measured by 
the MCMI-III; psychosis as measured be the MMS; psychosis as measured by the 
MCMI-III; and personality disorders as measured by the MCMI-III.   
 Model evaluation refers to an analysis of the amount of variance in the criterion 
variable that can be explained by the predictor variable (Pallant, 2007).  Typically, the 
‘adjusted R
2
’, which is found in the analysis, is multiplied by 100, which then provides 
the value as a percentage, indicating the extent to which the model explains the criterion 
variable.  Each model summary and ANOVA, to test for significance, will be reviewed in 
reference to each research question.  Following this, a review of the relationship between 
the predictor variable and criterion variable, as identified in the tables labeled as 
coefficients, will be reviewed. 
Research question 1:  Does depression, as measured by the PHQ-9, significantly 
predict relapse among individuals, within 90 days following alcohol detoxification?  
Tables 5 and 6 below show the results for model evaluation, inclusive of the predictor 
variable, depression as identified by the PHQ-9, and the criterion variable, number of 
days to relapse, within the first 90 days following initial detoxification, resulting in 
readmission for alcohol detoxification. In this instance, the model explains 7.6% of the 
variance in number of days to relapse, within the first 90 days following initial 
detoxification, resulting in readmission for alcohol detoxification, the criterion variable.  
Table 5 shows that this result is statistically significant (R = .311, R
2 
= .097, Adjusted R
2
 
= .076, p = .037).                                                                                       
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Table 5 
 
Model Summary
b
/Depression-PHQ-9 
 
 
Model 
 
R 
 
R
2 
 
Adjusted    
R
2 
 
Std. Error 
of the 
Estimate 
                    Change Statistics  
R
2
    
Change 
F  
Change 
df1 df2 Sig.                  
F 
Change 
 
1 .311
a
 .097 .076 11.640 .097 4.613 1 43 .037 
 
Criterion Variable:  Relapse 
 
 
Table 6 
 
ANOVA/Depression-PHQ-9 
 
Model Sum of 
Squares 
df Mean Square F Sig. 
Regression 625.036 1 625.036 4.613 .037
b
 
Residual 5826.208 43 135.493   
Total 6451.244 44    
Criterion Variable:  Relapse 
 
 As illustrated in Tables 6 above and 7 below, depression, as indicated by the 
PHQ-9 is statistically significant, however the percentage of variance accounted for is 
very low, suggesting a very weak ability to consider this variable a viable predictor of 
relapse [F(1, 43) = 4.613, p = .037]. This result means that the presence of depression, as 
indicated by the PHQ-9, does potentially make a contribution to the prediction of the 
criterion variable, number of days to relapse, within the first 90 days following initial 
detoxification, resulting in readmission for alcohol detoxification (Relapse = 7.687 x 
Depression + 1.706). However, as evidenced by the low R
2
 value (.097), depression as 
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measured by the PHQ-9 is a weak predictor of relapse in individuals that have previously 
been detoxified from alcohol.   
 According to Field (2005), any field that attempts to predict human behavior, such 
as psychology, typically has R
2
 values lower than .50, as humans are hard to predict.   
However, an R
2
 value of .097, as in this case, is extremely low, thus the likelihood of 
producing predictions that are reasonably precise are questionable.   
Table 7 
 
Coefficients/Depression - PHQ-9 
 
Model Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. 95.0% Confidence 
Interval for ß 
 ß Std.  
Error 
Beta   Lower 
Bound 
Upper 
Bound 
Constant 1.706 2.823  .604 .549 -3.988 7.399 
Depression 
PHQ-9  
7.687 3.579 .311 2.148 .037 .469 14.905 
Criterion Variable:  Relapse  
 
 
 Research question 2:  Does depression, as measured by the MMS, significantly 
predict relapse among individuals, within 90 days following alcohol detoxification?  
Tables 8 and 9 below show the results for model evaluation, inclusive of the predictor 
variable, depression as identified by the MMS, and the criterion variable, number of days 
to relapse, within the first 90 days following initial detoxification, resulting in 
readmission for alcohol detoxification.  In this instance, the model explains 6.3% of the 
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variance in relapse, the criterion variable. Table 8 shows that this result is not statistically 
significant as p > 0.05 (R = .291, R
2 
= .084, Adjusted R
2
 = .063, p = .053).  
Table 8 
Model Summary
b
/Depression-MMS 
 
 
Model 
 
R 
 
R
2 
 
Adjusted    
R
2 
 
Std. Error 
of the 
Estimate 
                    Change Statistics  
R
2
    
Change 
F  
Change 
df1 df2 Sig.                  
F Change  
1 .291
a
 .084 .063 11.720 .084 3.963 1 43 .053  
Criterion Variable:  Relapse 
Table 9 
ANOVA/Depression-MMS 
Model Sum of 
Squares 
df Mean 
Square 
F Sig. 
Regression 544.444 1 544.444 3.963 .053
b
 
Residual 5906.800 43 137.367   
Total 6451.244 44    
Criterion Variable:  Relapse 
 
 As illustrated in Tables 9 above and 10 below, depression, as indicated by the 
MMS is not statistically significant [F(1, 43) = 3.963, p = .053]. This result means that 
the presence of depression, as indicated by the MMS, does not make a statistically 
significant contribution to the prediction of the criterion variable, number of days to 
relapse, within the first 90 days following initial detoxification, resulting in readmission 
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for alcohol detoxification, therefore is not a predictor of relapse in individuals that have 
previously been detoxified from alcohol (Relapse = 7.000 x Depression + 2.600). 
Table 10 
 
Coefficients/Depression – MMS 
 
Model Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. 95.0% Confidence 
Interval for ß 
 ß Std.  
Error 
Beta   Lower 
Bound 
Upper 
Bound 
Constant 2.600 2.621  .992 .327 -2.685 7.885 
Depression 
MMS 
7.000 3.516 .291 1.991 .053 -.091 14.091 
Criterion Variable: Relapse  
 
 Research question 3:  Does depression, as measured by the MCMI-III, 
significantly predict relapse among individuals within 90 days following alcohol 
detoxification? Tables 11 and 12 below show the results for model evaluation, inclusive 
of the predictor variable, depression as identified by the MCMI-III, and the criterion 
variable, number of days to relapse, within the first 90 days following initial 
detoxification, resulting in readmission for alcohol detoxification. In this instance, the 
model explains 13.3% of the variance in number of days to relapse, the criterion variable.  
Table 11 shows that this result is statistically significant as p < 0.05 (R = .364, R
2 
= .133, 
Adjusted R
2
 = .112, p = .014).  
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Table 11 
 
Model Summary
b
/Depression-MCMI-III 
 
 
Model 
 
R 
 
R
2 
 
Adjusted    
R
2 
 
Std. Error 
of the 
Estimate 
                    Change Statistics  
R
2
    
Change 
F  
Change 
df1 df2 Sig.                  
F Change  
1 .364
a
 .133 .112 11.407 .133 6.576 1 43 .014  
Criterion Variable:  Relapse 
 
Table 12 
 
ANOVA/Depression-MCMI-III 
 
Model Sum of 
Squares 
df Mean 
Square 
F Sig. 
Regression 555.696 1 555.697 6.576 .014
b
 
Residual 5595.548 43 130.129   
Total 6451.244 44    
Criterion Variable:  Relapse 
 
 As illustrated in Tables 12 above and 13 below, depression, as indicated by the 
MCMI-III is statistically significant, however the percentage of variance accounted for is 
very low, suggesting a very weak ability to consider this variable a viable predictor of 
relapse [F(1, 43) = 6.576,  p = .014]. This result means that the presence of depression, as 
indicated by the MCMI-III, does potentially make a contribution to the prediction of the 
criterion variable, number of days to relapse, within the first 90 days following initial 
detoxification, resulting in readmission for alcohol detoxification (Relapse = 9.419 x 
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Depression + 1.017). However, as evidenced by the low R
2
 value (.133), depression as 
measured by the MCMI-III is a weak predictor of relapse in individuals that have 
previously been detoxified from alcohol.  
Table 13 
 
Coefficients/Depression-MCMI-III 
 
Model Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. 95.0% Confidence 
Interval for ß 
 ß   Std.    
Error 
Beta   Lower 
Bound 
Upper 
Bound 
Constant 1.017E-
013 
3.049  .000 1.000 -6.148 6.148 
Depression 
MCMI-III 
9.419    3.673      .364 2.564 .014 2.012 16.827 
Criterion Variable: Relapse  
  
Research question 4:  Does anxiety, as measured by the MMS, significantly 
predict relapse among individuals, within 90 days following alcohol detoxification?  
Tables 14 and 15 below show the results for model evaluation, inclusive of the predictor 
variable, anxiety as identified by the MMS, and the criterion variable, number of days to 
relapse, within the first 90 days following initial detoxification, resulting in readmission 
for alcohol detoxification. In this instance, the model explains 3.8% of the variance in 
relapse, the criterion variable. Table 14 shows that this result is, however, not statistically 
significant as p > 0.05 (R = .194, R
2 
= .038, Adjusted R
2
 = .015, p = .201).  
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Table 14 
Model Summary
b
/Anxiety-MMS 
 
 
Model 
 
R 
 
R
2 
 
Adjusted    
R
2 
 
Std. Error 
of the 
Estimate 
                    Change Statistics  
R
2
    
Change 
F  
Change 
df1 df2 Sig.                  
F Change  
1 .194
a
 .038 .015 12.015 .038 1.687 1 43 .201  
Criterion Variable:  Relapse 
 
Table 15 
ANOVA/Anxiety-MMS 
 
Model Sum of 
Squares 
df Mean 
Square 
F Sig. 
Regression 243.587 1 243.587 1.687 .201 
Residual 6207.658 43 144.364   
Total 6451.244 44    
Criterion Variable:  Relapse 
 
 As illustrated in Tables 15 above and 16 below, anxiety, as indicated by the MMS 
is not statistically significant [F(1, 43) = 1.687, p = 0.201]. This result means that the 
presence of anxiety, as indicated by the MMS, does not make a statistically significant 
contribution to the prediction of the criterion variable, number of days relapse, within the 
first 90 days following initial detoxification, resulting in readmission for alcohol 
detoxification, therefore is not a predictor of relapse in individuals that have previously 
been detoxified from alcohol (Relapse = 4.711 x Anxiety + 4.500). 
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Table 16 
 
Coefficients/Anxiety – MMS 
 
Model Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. 95.0% Confidence 
Interval for ß 
 ß Std.  
Error 
Beta   Lower 
Bound 
Upper 
Bound 
Constant 4.500 2.356  1.910 .063 -.252 9.252 
Anxiety 
MMS 
4.711 3.626 .194 1.299 .201 -2.603 12.024 
Criterion Variable: Relapse  
 
Research question 5:  Does anxiety, as measured by the MCMI-III, significantly 
predict relapse among individuals, within 90 days following alcohol detoxification?  
Tables 17 and 18 below show the results for model evaluation, inclusive of the predictor 
variable, anxiety as identified by the MCMI-III, and the criterion variable, number of 
days to relapse resulting in readmission for alcohol detoxification. In this instance, the 
model explains 2.4% of the variance in number of days to relapse, within the first 90 days 
following initial detoxification, resulting in readmission for alcohol detoxification, the 
criterion variable. Table 17 shows that this result is, however, not statistically significant 
as p > 0.05 (R = .155, R
2 
= .024, Adjusted R
2
 = .001, p = .308).  
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Table 17 
Model Summary
b
/Anxiety-MCMI-III 
 
 
Model 
 
R 
 
R
2 
 
Adjusted    
R
2 
 
Std. Error 
of the 
Estimate 
                    Change Statistics  
R
2
    
Change 
F  
Change 
df1 df2 Sig.                  
F Change  
1 .155
a
 .024 .001 12.100 .024 1.062 1 43 .308  
Criterion Variable:  Relapse 
Table 18 
ANOVA/Anxiety-MCMI-III 
 
Model Sum of 
Squares 
df Mean 
Square 
F Sig. 
Regression 155.506 1 155.506 1.062 .308 
Residual 6295.738 43 146.413   
Total 6451.244 44    
Criterion Variable:  Relapse 
 
 As illustrated in Tables 18 above and 19 below, anxiety, as indicated by the 
MCMI-III is not statistically significant [F(1, 43) = 1.062, p = 0.308]. This result means 
that the presence of anxiety, as indicated by the MCMI-III, does not make a statistically 
significant contribution to the prediction of the criterion variable, relapse, therefore is not 
a predictor of relapse in individuals that have previously been detoxified from alcohol 
(Relapse = 3.726 x Anxiety + 4.750). 
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Table 19 
Coefficients/Anxiety - MCMI-III 
 
Model Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. 95.0% Confidence 
Interval for ß 
 ß Std.  
Error 
Beta   Lower 
Bound 
Upper 
Bound 
Constant 4.750 2.470  1.923 .061 -.231 9.731 
Anxiety 
MCMI-
III 
3.726 3.616 .155 1.031 .308 -3.565 11.018 
Criterion Variable: Relapse  
 
Research question 6:   Does psychosis, as measured by the MMS, significantly 
predict relapse among individuals, within 90 days following alcohol detoxification?  
Tables 20 and 21 below show the results for model evaluation, inclusive of the predictor 
variable, psychosis as identified by the MMS, and the criterion variable, number of days 
to relapse, within the first 90 days following initial detoxification, resulting in 
readmission for alcohol detoxification. In this instance, the model explains 3.0% of the 
variance in number of days to relapse, resulting in readmission for alcohol detoxification, 
the criterion variable. Table 20 shows that this result is, however, not statistically 
significant as p > 0.05 (R = .175, R
2 
= .030, Adjusted R
2
 = .008, p = .251).  
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Table 20 
Model Summary
b
/Psychosis-MMS 
 
 
Model 
 
R 
 
R
2 
 
Adjusted    
R
2 
 
Std. Error 
of the 
Estimate 
                    Change Statistics  
R
2
    
Change 
F  
Change 
df1 df2 Sig.                  
F Change  
1 .175
a
 .030 .008 12.061 .030 1.351 1 43 .251  
Criterion Variable:  Relapse 
Table 21 
ANOVA/Psychosis-MMS 
 
Model Sum of 
Squares 
df Mean 
Square 
F Sig. 
Regression 196.544 1 196.544 1.351 .251 
Residual 6254.700 43 145.458   
Total 6451.244 44    
Criterion Variable:  Relapse 
 
 As illustrated in Tables 21 above and 22 below, psychosis, as indicated by the 
MMS is not statistically significant [F(1, 43 = 1.351, p = 0.251]. This result means that 
the presence of psychosis, as indicated by the MMS, does not make a statistically 
significant contribution to the prediction of the criterion variable, number of days to 
relapse, within the first 90 days following initial detoxification, resulting in readmission 
for alcohol detoxification, therefore is not a predictor of relapse in individuals that have 
previously been detoxified from alcohol (Relapse = 6.650 x Psychosis + 5.750). 
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Table 22 
Coefficients/Psychosis – MMS 
 
Model Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. 95.0% Confidence 
Interval for ß 
 ß Std.  
Error 
Beta   Lower 
Bound 
Upper 
Bound 
Constant 5.750 1.907  3.015 .004 1.904 9.596 
Psychosis 
MMS 
6.650 5.721 .175 1.162 .251 -4.887 18.187 
Criterion Variable: Relapse  
 
Research question 7:  Does psychosis, as measured by the MCMI-III, 
significantly predict relapse among individuals, within 90 days following alcohol 
detoxification? Tables 23 and 24 below show the results for model evaluation, inclusive 
of the predictor variable, psychosis as identified by the MCMI-III, and the criterion 
variable, number of days to relapse, resulting in readmission for alcohol detoxification.  
In this instance, the model explains 3.0% of the variance in number of days to relapse, 
within the first 90 days following initial detoxification, resulting in readmission for 
alcohol detoxification services, the criterion variable. Table 23 shows that this result is, 
however, not statistically significant as p > 0.05 (R = .175, R
2 
= .030, Adjusted R
2
 = .008, 
p = .251). In this case the results using the MMS and the MCMI-III are identical as both 
instruments consistently identified the same individuals as positive for psychosis. 
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Table 23 
Model Summary
b
/Psychosis-MCMI-III 
 
 
Model 
 
R 
 
R
2 
 
Adjusted    
R
2 
 
Std. Error 
of the 
Estimate 
                    Change Statistics  
R
2
    
Change 
F  
Change 
df1 df2 Sig.                  
F Change  
1 .175a .030 .008 12.061 .030 1.351 1 43 .251  
Criterion Variable:  Relapse 
Table 24 
ANOVA/Psychosis-MCMI-III 
 
Model Sum of 
Squares 
df Mean 
Square 
F Sig. 
Regression 196.544 1 196.544 1.351 .251 
Residual 6254.700 43 145.458   
Total 6451.244 44    
Criterion Variable:  Relapse 
 
 As illustrated in Table 25 below, psychosis, as indicated by the MCMI-III is not 
statistically significant [F(1, 43 = 1.351, p = .251].  This result means that the presence of 
psychosis, as indicated by the MMS, does not make a statistically significant contribution 
to the prediction of the criterion variable, number of days to relapse, within the first 90 
days following initial detoxification, resulting in readmission for alcohol detoxification, 
therefore is not a predictor of relapse in individuals that have previously been detoxified 
from alcohol (Relapse = 6.650 x psychosis + 5.750). 
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Table 25 
Coefficients/Psychosis - MCMI-III 
 
Model Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. 95.0% Confidence 
Interval for ß 
 ß Std.  
Error 
Beta   Lower 
Bound 
Upper 
Bound 
Constant 5.750 1.907  3.015 .004 1.904 9.596 
Psychosis 
MMS 
6.650 5.721 .175 1.162 .251 -4.887 18.187 
Criterion Variable: Relapse  
 
 Research question 8:  Do personality disorders, as measured by the MCMI-III, 
significantly predict relapse among individuals, within 90 days following alcohol 
detoxification? Tables 26 and 27 below show the results for model evaluation, inclusive 
of the predictor variable, personality disorders as identified by the MCMI-III, and the 
criterion variable, number of days to relapse, within the first 90 days following initial 
detoxification, resulting in readmission for alcohol detoxification. In this instance, the 
model explains 2.9% of the variance in relapse, the criterion variable.  Table 26 shows 
that this result is, however, not statistically significant as p > 0.05 (R = .171, R
2 
= .029, 
Adjusted R
2
 = .007, p = .261). 
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Table 26 
Model Summary
b
/Personality Disorders-MCMI-III 
 
 
Model 
 
R 
 
R
2 
 
Adjusted    
R
2 
 
Std. Error 
of the 
Estimate 
                    Change Statistics  
R
2
    
Change 
F  
Change 
df1 df2 Sig.                  
F Change  
1 .171
a
 .029 .007 12.068 .029 1.295 1 43 .261  
Criterion Variable:  Relapse 
Table 27 
ANOVA/Personality Disorders-MCMI-III 
 
Model Sum of 
Squares 
df Mean 
Square 
F Sig. 
Regression 188.604 1 188.604 1.295 .261 
Residual 6262.640 43 145.643   
Total 6451.244 44    
Criterion Variable:  Relapse 
 
 
 As illustrated in Table 28 below, personality disorders, as indicated by the 
MCMI-III is not statistically significant [F(1, 43 = 1.295, p = .261]. This result means 
that the presence of a personality disorder, as indicated by the MCMI-III, does not make 
a statistically significant contribution to the prediction of the criterion variable, number of 
days to relapse, within the first 90 days following initial detoxification, resulting in 
readmission for alcohol detoxification, therefore is not a predictor of relapse in 
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individuals that have previously been detoxified from alcohol (Relapse = 4.120 x 
Personality Disorders + 4.200). 
 
Table 28 
 
Coefficients/Personality Disorder - MCMI-III 
 
Model Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. 95.0% Confidence 
Interval for ß 
 ß Std.  
Error 
Beta   Lower 
Bound 
Upper 
Bound 
Constant 4.200 2.699  1.556 .127 -1.242 9.642 
Personality 
Disorder 
MCMI-III 
4.120 3.620 .171 1.138 .261 -3.181 11.421 
Criterion Variable: Relapse  
 
 
Of additional interest in relation to the predictor variable, personality disorders, is 
that 15 of 25 individuals (60%) that were identified as having a personality disorder 
relapsed, resulting of readmission for alcohol detoxification services. All 15 of those that 
relapsed were positive for depression in addition to a personality disorder, and 13 of the 
15 had both depression and anxiety, in addition to a personality disorder. Therefore, in 
the study population, personality disorders do not appear to stand in isolation from other 
mental health disorders.      
Summary 
Eight bivariate linear regressions, involving all 45 study participants, were 
conducted to examine the eight research questions:  
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1. Does depression, as measured by  the PHQ-9, significantly predict relapse 
among individuals, within 90 days following alcohol detoxification? 
2. Does depression, as measured by the MMS, significantly predict relapse 
among individuals, within 90 days following alcohol detoxification? 
3. Does depression, as measured by the MCMI-III, significantly predict 
relapse among individuals, within 90 days following alcohol 
detoxification?  
4. Does anxiety, as measured by the MMS, significantly predict relapse 
among individuals, within 90 days following alcohol detoxification?  
5. Does anxiety, as measured by the MCMI-III, significantly predict relapse 
among individuals, within 90 days following alcohol detoxification?  
6. Does psychosis, as measured by the MMS, significantly predict relapse 
among, individuals within 90 days following alcohol detoxification? 
7. Does psychosis, as measured by the MCMI-III, significantly predict 
relapse among individuals, within 90 days following alcohol 
detoxification? 
8. Do personality disorders, as measured by the MCMI-III, significantly 
predict relapse among individuals, within 90 days following alcohol 
detoxification?   
Each research question examined whether the predictor variables, as measured by 
results from the three instruments used, were able to predict relapse resulting in alcohol 
detoxification within 90 days from the previously detoxification episode. 
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Support was found for the alternative hypothesis in research questions 1 and 3, 
related to depression and relapse. Thus depression as identified by the PHQ-9 and 
MCMI-III was able to predict, however not very precisely, the criterion variable, number 
of days to relapse, within the first 90 days following initial detoxification, resulting in 
readmission for alcohol detoxification services. Therefore, in the population studied, the 
presence of depression, as measured by the PHQ-9 and the MCMI-III are weak predictors 
of relapse resulting in readmission for alcohol detoxification. Even though these 
predictors were statistically significant, they are very weak because they are not able to 
produce predictions that are reasonably precise as evidenced by the low R
2
 values 
associated with them (R
2  
= .097, Adjusted R
2 
= .076 for depression as measured by the 
PHQ-9; and R
2  
= .133, Adjusted R
2
 = .112 for depression as measured by the MCMI-III). 
 The predictor variables of; depression as identified by the MMS, anxiety as 
identified by the MMS; anxiety as identified by the MCMI-III, psychosis as identified by 
the MMS; psychosis as identified by the MCMI-III, and personality disorders as 
identified by the MCMI-III  were not able to predict the criterion variable, number of 
days to relapse, within the first 90 days following initial detoxification, resulting in 
readmission for alcohol detoxification. Therefore the null hypotheses, as stated in 
research questions 2, 4, 5, 6, 7, and 8 was supported. The predictor variables did not 
significantly predict relapse in previously detoxified individuals. 
As noted earlier, a key element of this study design was the use of multiple 
instruments that measure similar clinical issues. This strategy was used to determine if a 
simpler instrument, rather than a more exhaustive instrument, was able to produce 
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equitable results. Instrumentation included a standardized screening instrument (MMS), a 
brief depression assessment (PHQ-9), and a test that identifies Axis I & Axis II disorders 
(MCMI-III). In the study conducted, one of the simpler instruments, the PHQ-9 produced 
results very similar to the more complex tool, the MCMI-III when applying the predictor 
variable of depression. Although the MCMI-III demonstrated more sensitivity, by 
identifying 4 more individuals with depression than the MMS and 3 more than the PHQ-
9, the time required for testing and scoring is substantially increased with the MCMI-III. 
 The MMS and the MCMI-III were used to identify anxiety in the study 
population. Again, the MCMI-III demonstrated more sensitivity and was able to identify 
2 individuals with anxiety that were missed by the MMS. Psychosis was identified 
equally by both the MMS and MCMI-III. The MCMI-III was the only instrument utilized 
to identify personality disorders; therefore a comparison is not able to be made. Chapter 5 
will provide interpretation of the findings, discuss limitations of the study, describe 
recommendations for further research, and discuss implications for social change. 
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Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
 This chapter provides a discussion and summary of the statistical analyses and 
 
findings for each of the study’s research questions, along with the assimilation of 
 
previous research and the self-medication hypothesis. Additionally, an explanation of the 
limitations of the study and suggestions for future research will be addressed. 
The purpose of this study was to identify predictors of relapse in patients 
detoxified from alcohol. Predictor variables of this study included depression, anxiety, 
psychosis, and personality disorders as measured by three different instruments (PHQ-9; 
MMS; and MCMI-III). The criterion variable involved in this study was number of days 
to relapse, within the first 90 days following initial detoxification, resulting in 
readmission for alcohol detoxification. In addition, this researcher sought to contribute to 
the existing research about the relationship between mental health disorders and relapse 
in patients previously detoxified from alcohol. 
Data for this study were collected by staff from a public behavioral health facility, 
located in central Wisconsin, and provided to this researcher for analyses. The statistical 
approach of bivariate linear regression was applied to analyze the data utilizing SPSS 
software. Data was analyzed to determine whether the selected predictor variables, 
depression, anxiety, psychosis, and personality disorders, were able to significantly 
predict the criterion variable, number of days to relapse, within the first 90 days 
following initial detoxification, resulting in readmission for alcohol detoxification.  
The research questions presented in this study were as follows: 
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1. Does depression, as measured by  the PHQ-9, significantly predict relapse 
among individuals, within 90 days following alcohol detoxification?  
2. Does depression, as measured by the MMS, significantly predict relapse 
among individuals, within 90 days following alcohol detoxification?  
3. Does depression, as measured by the MCMI-III, significantly predict 
relapse among individuals, within 90 days following alcohol 
detoxification?  
4. Does anxiety, as measured by the MMS, significantly predict relapse 
among individuals, within 90 days following alcohol detoxification?  
5. Does anxiety, as measured by the MCMI-III, significantly predict relapse 
among individuals, within 90 days following alcohol detoxification? 
6. Does psychosis, as measured by the MMS, significantly predict relapse 
among, individuals within 90 days following alcohol detoxification?  
7. Does psychosis, as measured by the MCMI-III, significantly predict 
relapse among individuals, within 90 days following alcohol 
detoxification?  
8. Do personality disorders, as measured by the MCMI-III, significantly 
predict relapse among individuals, within 90 days following alcohol 
detoxification?                                                          
Based on the results of analysis presented in Chapter 4, the null hypotheses were 
rejected for research questions 1 and 3, thus the research (alternate) hypotheses were 
supported. The presence of depression, as identified by the PHQ-9 and MCMI-III, were 
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able to statistically predict the criterion variable, number of days to relapse, within the 
first 90 days following initial detoxification, resulting in readmission for alcohol 
detoxification services. However, the actual predictive ability was very low, thus these 
predictor variables did not demonstrate the ability to produce predictions that can be 
considered reasonably precise   
Of primary significance, 100% (N = 24) of the individuals that relapsed within 90 
days, requiring subsequent alcohol detoxification, were positive for depression.  This 
means that all individuals that relapsed, who were positive for any disorder, also had 
depression. Therefore, the presence of a negative affective state was present in all 
individuals that relapsed.  
 The research conducted for this dissertation, supports the findings of Cacciola et 
al. (2001), as the presence of depression was found to be prevalent in the population of 
individuals that relapsed to alcohol use after previously being detoxified. Cacciola et al. 
conducted an extensive literature review examining prevalence rates of mental health 
disorders in addiction treatment settings. These authors reported a consistent pattern 
emerged, indicating that people with alcohol use disorders are likely to suffer from mood 
and anxiety disorders.  
 The null hypotheses were supported for research questions 2, 4, 5, 6, 7, and 8, 
thus the research hypotheses must be set aside. The predictor variables; depression as 
identified by the MMS, anxiety as identified by the MMS, anxiety as identified by the 
MCMI-III, psychosis as identified by the MMS, psychosis as identified by the MCMI-III, 
and personality disorders as identified by the MCMI-III, were not able to predict the 
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criterion variable, number of days to relapse, within the first 90 days following initial 
detoxification, resulting in readmission for alcohol detoxification. However, the small 
sample size of the study population may have produced results that are not an accurate 
reflection of the prediction capacity that anxiety, psychosis, and personality disorders 
have on relapse. 
    Interpretation of Findings                                                                                              
 The literature presented in this study supported the significance of mental health 
disorders as they relate to the issue of relapse to alcohol use in previously detoxified 
individuals. Identifying mental health disorders in individuals who present for alcohol 
detoxification, and subsequently referring these individuals to the appropriate treatment 
services, provides the opportunity to address the source of the issue, thus enhancing the 
potential for recovery and reduce the risk of relapse (Bradizza, et al., 2009). If such 
individuals are not identified, appropriate referrals may not occur. 
 This research added to the literature base related to the co-occurrence of mental 
health disorders and substance use disorders. Predicting relapse after alcohol 
detoxification is important to ensure that people are directed to the most appropriate 
aftercare services (Pederson & Hesse, 2009). Pederson and Hesse also stated that a valid 
and practical instrument for predicting risk for relapse does not exist; therefore 
individuals may not be correctly targeted for aftercare services. Even though the sample 
size for the research conducted for this dissertation was small, results do suggest that 
existing instruments may be very useful for identifying individuals with co-occurring 
disorders, including the prediction of relapse to alcohol use in those with depression.   
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 If individuals are not provided with the appropriate aftercare services, the 
likelihood of relapse increases (Nakajima & al’Absi, 2012). Lagoni et al. (2011) reported 
that individuals with mental health disorders are significantly more likely to have alcohol 
use disorders as compared to the general population, are less likely to be successful in 
treatment, and are more likely to relapse following treatment.   
Self-Medication Hypothesis                                                                                           
 The findings from this research add to the literature base related to the theoretical 
framework of the study used as a model, that being, the self-medication hypothesis.  
From the earliest studies, reviewed in Chapter 2 of this dissertation, to present day, the 
self-medication hypothesis has been supported by evidence substantiating the link 
between using substances and negative affective states.    
Primary theoretical propositions of the self-medication hypothesis include: some 
individuals have an inability to tolerate strong negative affect; the inability to tolerate 
strong affect is a primary motivator for substance use in these individuals; and mental 
health conditions are the causal agent in substance use. Chakroun, Johnson, and 
Swendsen (2010) provided support for these propositions by reporting certain individuals 
use substances in an attempt to self-medicate intolerable affective states.   
According to this hypothesis, an individual's use of alcohol or other substances is 
not accidental, but chosen for its ability to relieve distressing symptoms or feelings 
(McDonald & Meyer, 2011). Considering these propositions, the results of the research 
conducted for this dissertation do provide some reinforcement for the validity of the self-
medication hypothesis, as 100% of study participants that did relapse within the first 90 
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days following initial detoxification, resulting in readmission for alcohol detoxification, 
were identified by the instruments used, as having depression.    
Early research conducted by Khantzian (1985), Bibb and Chambless (1986),  
Heinz et al. (1999), Franken and Hendriks (1999), Strowing (2000), and Driessen et al. 
(2001) through more current research as conducted by Chakroun et al. (2010), Littlefield 
and Sher (2010), and Dick et al. (2010) was supported by the current research, as all have 
indicated the presence of depression increases the risk of relapse in individuals who have 
stopped using alcohol. Thus all the aforementioned studies support the self-medication 
hypothesis. 
  The National Institute of Mental Health Epidemiologic Catchment Area study 
was one of the earliest studies conducted and included 9,543 individuals aged 18 to 30 
years. This study was designed to explore the sequence of mental health disorders and 
substance abuse. The results of this study supported the self-medication hypothesis as it 
found 75% of individuals reported the development of their affective disorder prior to the 
onset of their substance abuse disorder (Christie et al., 1988). In spite of the small sample 
size of the study conducted for this dissertation, it is imperative to recognize that 100% of 
the individuals that relapsed were positive for depression. The current results support and 
align with the large scale research conducted by Christie et al. in 1988.    
Research Question 1 
 Does depression, as measured by the PHQ-9, significantly predict relapse among 
individuals, within 90 days following alcohol detoxification?  
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The current study found that depression, as indicated by the PHQ-9, was able to 
predict relapse, however at a very low level, in individuals that had previously been 
detoxified from alcohol. Depression, as indicated by the PHQ-9 was statistically 
significant (R = .311,  R
2 
= .097,  Adjusted R
2
 = .076,  p = .037). The PHQ-9 was not as 
sensitive as the MCMI-III, however did produce results that were statistically significant.  
The PHQ-9 tool is a simple to use instrument and takes only a few minutes for 
individuals to complete. Scoring of the PHQ-9 is also simple, which makes it an 
attractive tool for clinical staff to use. The PHQ-9 is also used universally, across care 
systems and therefore requires little interpretation between providers.   
Research Question 2 
 Does depression, as measured by the MMS, significantly predict relapse among 
individuals, within 90 days following alcohol detoxification?  
The current study found that depression, as indicated by the MMS, was not able to 
significantly predict relapse in individuals that had previously been detoxified from 
alcohol. Depression, as indicated by the MMS was not statistically significant                 
(R = .291, R
2 
= .084, Adjusted R
2
 = .063, p = .053). The MMS is a simple to use 
instrument that screens for depression, anxiety, and psychosis. The MMS was not as 
sensitive as the PHQ-9 or MCMI-III and did not produce results that were statistically 
significant. A benefit of the MMS is that is screens for multiple disorders, rather than just 
one disorder.                                                                                                              
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Research Question 3                                                                                                    
Does depression, as measured by the MCMI-III, significantly predict relapse 
among individuals, within 90 days following alcohol detoxification?  
The current study found that depression, as indicated by the MCMI-III, was able 
to predict relapse, however at a very low level, in individuals that had previously been 
detoxified from alcohol. Depression, as indicated by the MCMI-III was statistically 
significant (R = .364, R
2 
= .133, Adjusted R
2
 = .112, p = .014). The MCMI-III is a test 
that screens for mental health disorders and personality disorders. The MCMI-III was the 
most sensitive instrument used in that it identified more individuals with depression than 
any of the instruments used. Use of the MCMI-III required a significant time 
commitment from both the study participants and the facility staff.   
Research Question 4  
 Does anxiety, as measured by the MMS, significantly predict relapse among 
individuals, within 90 days following alcohol detoxification?  
 The current study found that anxiety, as indicated by the MMS, is not able to 
predict relapse in individuals that have previously been detoxified from alcohol. Anxiety, 
as indicated by the MMS was not statistically significant (R = .194, R
2 
= .038, Adjusted 
R
2
 = .015, p = .201). As mentioned in the information presented above on Research 
Question 2, the MMS is a simple to use instrument that screens for depression, anxiety, 
and psychosis. The MMS was not as sensitive as the MCMI-III, however neither the 
MMS nor the MCMI-III produced results that were statistically significant in regard to 
the variable of anxiety.   
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Research Question 5 
 Does anxiety, as measured by the MCMI-III, significantly predict relapse among 
individuals, within 90 days following alcohol detoxification? 
The current study found that anxiety, as indicated by the MCMI-III, is not able to 
predict relapse in individuals that have previously been detoxified from alcohol. Anxiety, 
as indicated by the MCMI-III was not statistically significant (R = .155, R
2 
= .024, 
Adjusted R
2
 = .001, p = .308). The MCMI-III was the most sensitive instrument used in 
that it identified more individuals with anxiety than any of the instruments used, however 
was not able to predict the criterion variable, relapse. Again, this may due to the small 
sample size of the study. 
Research Question 6 
 Does psychosis, as measured by the MMS, significantly predict relapse among, 
individuals within 90 days following alcohol detoxification?  
The current study found that psychosis, as indicated by the MMS, was not able to 
predict relapse in individuals that have previously been detoxified from alcohol.  
Psychosis, as indicated by the MMS was not statistically significant (R = .175, R
2 
= .030, 
Adjusted R
2
 = .008, p = .251). As mentioned in the information presented above on 
Research Questions 2 and 4, the MMS is a simple to use instrument that screens for 
depression, anxiety, and psychosis.   
The MMS was equally as sensitive as the MCMI-III, identifying the same number 
of individuals with psychosis, however did not produce results that were statistically 
significant. In the population studied, only 5 individuals scored positive for psychosis.  
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This small study sample size makes it difficult to provide any meaningful interpretations 
about the findings.   
Research Question 7 
 Does psychosis, as measured by the MCMI-III, significantly predict relapse 
among individuals, within 90 days following alcohol detoxification?  
The current study found that psychosis, as indicated by the MCMI-III, was not 
able to predict of relapse in individuals that have previously been detoxified from 
alcohol. Psychosis, as indicated by the MCMI-III was not statistically significant  
(R = .175, R
2 
= .030, Adjusted R
2
 = .008, p = .251). As mentioned in the information 
presented above regarding Research Question 7, the MMS was equally as sensitive as the 
MCMI-III, identifying the same number of individuals with psychosis. However, only 5 
individuals scored positive for psychosis of the study population of 45. Again, this small 
sample of individuals with psychosis makes it difficult to provide any meaningful 
interpretations about the findings. 
Research Question 8 
 Do personality disorders, as measured by the MCMI-III, significantly predict 
relapse among individuals, within 90 days following alcohol detoxification?   
The current study found that personality disorders, as indicated by the MCMI-III, 
were not able to predict relapse in individuals that had previously been detoxified from 
alcohol. Personality disorders, as indicated by the MCMI-III were not statistically 
significant (R = .171, R
2 
= .029, Adjusted R
2
 = .007, p = .261). Fifteen, of the 25 
individuals, who were identified as having a personality disorder relapsed (60%).  Of 
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particular interest is that all 15 had another mental health disorder in addition to the 
personality disorder. All 15 individuals that relapsed had depression in addition to a 
personality disorder, and 13 of the 15 had both depression and anxiety in addition to a 
personality disorder.   
Therefore, in the study population, personality disorders do not appear to stand in 
isolation from other mental health disorders. This information suggests the presence of 
personality disorders is common in the population of people that receive detoxification 
services and have depression and anxiety.   
While the results of this study do not support the predictive capability of 
personality disorders, research conducted with larger samples have supported this. 
Chávez, Dinsmore, and Hof conducted research in 2010 and found that being diagnosed 
with a personality disorder is a strong predictor of alcohol use disorders. Therefore, 
results from this study need to be considered within the appropriate context. 
Limitations of the Study 
A limitation of this study involves the internal validity of the data from the 
instrumentation used. All instruments completed by individuals were self-report 
measures. Although, each of the instruments used in this study have been thoroughly 
researched and tested, and have been determined to be valid and reliable, studies that use 
self-report measures have potential validity and reliability concerns (Kroenke & Spitzer, 
2002). Individuals may over-report or under-report the severity or frequency of 
symptoms in order to maximize or minimize their problems which presents the potential 
of inaccuracy and trustworthiness of the data obtained.   
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In general, screening tools have inherent limitations related to the potential of 
either under-identify or over-identify the conditions they are designed to detect. In the 
present study a screening tool, the MMS, was used. The MMS identified 6 fewer 
individuals with depression than the MCMI-III and 3 fewer than the PHQ-9.  
Additionally, the MMS identified 2 fewer individuals with anxiety than the MCMI-III.  
This screening tool identified the same number of individuals with psychosis as the 
MCMI-III. The MMS produced significant results in the present study, however was not 
as sensitive as the MCMI-III and PHQ-9. Given that 3 different instruments were utilized 
for this study, limitations regarding instrumentation were minimized. 
The PHQ-9 was developed and normed on patients presenting in primary care and 
has not been thoroughly examined for administration to patients with mental health 
disorders (Inoue et al., 2012). The present study occurred within a behavioral health 
facility and the study population was specific to individuals that had been provided 
alcohol detoxification services. Even though detoxification is a medical intervention, the 
study population was drawn from a behavioral health setting, rather than a primary care 
setting. The strategy of using multiple instruments was selected to minimize the 
limitations each instrument has independently.                                                                                          
 The primary limitation of the MCMI-III is the potential for occasional 
misidentification of personality disorders due to the lack of a distinct division between 
Axis I (major mental health disorders) and Axis II (personality disorders) phenomena. In 
this study, the MCMI-III demonstrated the greatest ability to identify any disorder in the 
study population. However, considering this was the only instrument used to identify 
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personality disorders it is not possible to determine if misidentification occurred. This is a 
limitation of this study.   
An additional limitation of this study was the homogeneity of the population.  
Forty-three of the 45 (95.56%) of the population was Caucasian/White, therefore, this 
research cannot be generalized to non-Caucasian/non-White populations. Additionally, 
33 of the 45 (73.3%) individuals were male, resulting in additional caution being required 
when considering applying the results of this research to other populations. Readers of 
this research must keep these limitations in mind to ensure that results are not generalized 
or interpreted beyond the scope intended.  
Using a convenience sample is another limitation that needs to be acknowledged.   
This study population may not be representative of the entire population, therefore 
limiting the generalizability of the study results. 
Although no significant findings related to relapse in the study population with 
personality disorders were identified, earlier studies have reported such a connection.  
Therefore, the small sample size may have been a limiting factor in assessing this 
variable.    
Recommendations for Future Research 
The findings in this study do contribute to an area of study in which information 
is lacking in regards to mental health disorders and relapse in individuals previously 
detoxified from alcohol. Future studies should focus on the actual scores from the 
instruments used to determine if a relationship between the severity of the mental health 
disorder and relapse exists.    
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 Considering this study utilized bivariate linear regression, this resulted in very 
little predictability. Research utilizing multiple linear regression would provide future 
researchers the ability to examine the potential increase in  R
2
 if all of the potential 
predictor variables used in this study were in linear combination.   
Future studies should also examine the relationship between aftercare services and 
relapse to alcohol use requiring subsequent detoxification services. Again, this will assist 
behavioral health providers to apply scarce resources to the population that will likely 
have the most significant benefit.   
The study sample for this research was taken from a public behavioral health 
facility located in central Wisconsin with a large Caucasian population. Applying such a 
study, using a diverse population, is recommended to improve the generalization of 
findings.   
Implications for Positive Social Change 
The current study has important implications for positive social change. The 
results may encourage behavioral health providers to recognize the importance of 
identifying mental health disorders, particularly depression, in the population of people 
that present for alcohol abuse services.   
The literature review presented in this study supported the need for identifying 
mental health disorders in individuals that present for alcohol detoxification services, 
however the results from the present study did not provide a significant contribution to 
supporting this need. Predicting relapse after alcohol detoxification is important to ensure 
that people are directed to the most appropriate aftercare services (Pederson & Hesse, 
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2009). These authors shared that a valid and practical instrument for predicting risk for 
relapse does not exist; therefore may not be correctly targeted for aftercare services.   
If individuals are not provided with the appropriate aftercare services, the 
likelihood of relapse increases (Nakajima & al’Absi, 2012). The current research 
demonstrated the use of existing instruments, that are simple to use, do yield useful 
information and are able to identifying those individuals that are most likely to relapse. 
The PHQ-9 demonstrated the ability to identify depression and yield significant results 
related to predicting the criterion variable number of days to relapse, within the first 90 
days following initial detoxification, resulting in readmission for alcohol detoxification.  
Correctly identifying individuals and providing them with the appropriate aftercare 
services; has the potential of improving their lives, decreasing repetitive use of 
detoxification services, and improving overall social conditions 
Conclusion 
This study focused on the relationship between mental health disorders and 
relapse in individuals that had previously been detoxified from alcohol. The study 
examined the ability of depression as identified by the PHQ-9, depression as identified by 
the MMS, depression as identified by the MCMI-III, anxiety as identified by the MMS, 
anxiety as identified by the MCMI-III, psychosis as identified by the MMS, psychosis as 
identified by the MCMI-III, and personality disorders as identified by the MCMI-III, to 
predict the criterion variable, number of days to relapse, within the first 90 days 
following initial detoxification, resulting in readmission for alcohol detoxification 
services. 
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The study utilized 3 different tools, of varying complexity, to identify mental 
health disorders, a standardized screening instrument (MMS), a brief depression 
assessment (PHQ-9), and a test that identified Axis I & Axis II disorders (MCMI-III).  
One of the simpler tools, the PHQ-9, yielded results comparable to the more complex 
tool, the MCMI-III for the predictor variable, depression. Depression as indicated by the 
MMS did not demonstrate the ability to predict the criterion variable, number of days to 
relapse, within the first 90 days following initial detoxification, resulting in readmission 
for alcohol detoxification services. 
 Anxiety as identified by the MMS and MCMI-III, psychosis as identified by the 
MMS and MCMI-II, and personality disorders as identified by the MCMI-III did not 
demonstrate the ability to predict the criterion variable, number of days to relapse, was 
within the first 90 days following initial detoxification, resulting in readmission for 
alcohol detoxification services. However, as mentioned earlier, the sample size was very 
small, which may have skewed the results of this study.   
Considering all individuals that relapsed scored positive for depression, this 
should be a primary focus for identification by behavioral health providers providing 
substance abuse services. The PHQ-9 is a very simple to use tool and is designed 
specifically to identify depression.  In the current study, the PHQ-9 was able to identify 
slightly more individuals with depression as compared to the MMS. The findings from 
the current study support findings of the study conducted by Weiss, et al. (1992) as 
reviewed in Chapter 2. The Weiss, et al. study found that 100% of men and 81% of 
women that were diagnosed with depression reported abusing substances for self-
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medicative purposes. These results suggest that a primary component of the self-
medication hypothesis, the desire to reduce depressive symptoms, was acknowledged in 
the majority of those who abuse substances.   
The purpose of this study was to identify predictors of relapse among individuals 
detoxified from alcohol. The research presented in this study supports the self-medication 
hypothesis and demonstrates the importance of identifying mental health disorders, 
specifically depression, in individuals that present for alcohol detoxification services.  
Identification of mental health disorders provides behavioral health professionals the 
ability to provide individuals with the appropriate treatment, which includes referral to 
aftercare services. The ability to predict relapse after treatment for detoxification from 
alcohol may be useful to ensure that individuals who have the highest need for aftercare 
services are identified and to make the best use of the limited resources that are available 
(Pedersen & Hesse, 2009). Providing detoxification services in isolation from mental 
health services, for individuals that have a co-occurring mental health disorder, is simply 
treating the symptom, rather than the cause.   
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